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ABSTRACT 
Introduction: 
Heart failure (HF) in combination with multiple chronic conditions is increasing rapidly, 
mainly in the elderly. Self-care is presumed to be one of the best practices for chronic illness 
including HF. Most of HF-related costs are attributed to hospitalizations with poor HF self-
care as an important cause. The complexity of self-care leads to poor adherence to self-care. 
Mobile health (mHealth) and the use of technology has the possibility to support persons with 
HF and families to engage in self-care. Other strategies for improving self-care can be physi-
cal activities, known to improve cardiorespiratory and muscular fitness/strength, functional 
health, maintained cognitive function, reduction of anxiety and depression together with 
improved self-esteem. Self-care with yoga may be an alternative to exercise training and in-
crease quality of life. 
Aim:  
The overall aim of this thesis was to describe experiences and evaluate the effects of innova-
tive self-care approaches such as the mHealth system and yoga among persons with heart 
failure.  
Methods:  
The thesis is based on four studies using both quantitative and qualitative methods. Study I 
and II used an RCT design with follow-up assessment after three and six months including 82 
persons with heart failure. The control group received care as usual. Data was collected using 
questionnaires before and after tree and six months to determine the long-term effects on self-
care, HRQoL, knowledge and hospitalization (I, II). To evaluate the experiences from the 
mHealth system a qualitative study with interviews where performed including 17 persons in 
study III. Study IV was conducted as a RCT study with 40 persons with HF, receiving either 
hydrotherapy or yoga. Evaluation before and after three months included HRQoL, six-minute 
walk test, sit-to-stand test, clinical variables, anxiety and depression.  
Results:  
The mHealth intervention resulted in improved self-care, HRQoL and reduction in hospitali-
zation days after both three and six months. Knowledge improved significantly after six 
months. Adherence to the mHealth system was high around 85%. Insight in the importance of 
adherence to self-care through daily weighing, was enhanced by the repeated reminder and 
instant feed-back from the mHealth system gathered from experiences. Technical adversities 
were common with a need of quick and easy support. Yoga and hydrotherapy had an equal 
impact on HRQoL, exercise capacity, clinical outcomes, anxiety and depression.  
Conclusions:  
The mHealth tool strengthened adherence to weighing, improved self-care, HRQoL and re-
duced HF hospitalization days, together with improved HF knowledge after six months. Self-
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care was obtained through understanding the deteriorating symptoms and signs, in connection 
to weight change and how to act. The experiences of mHealth could be determined in relation 
to “the situation specific theory of heart failure self-care”. Yoga could serve as a complement 
or alternative to exercise training such as hydrotherapy in persons with heart failure. 
Keywords: Heart failure, self-care, mHealth, yoga, health related quality of life, depression, 
anxiety. 
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1 INTRODUCTION 
1.1 PREFACE 
Imagine a world where the treasures of knowledge could be left to those who comes after. 
Now we are not living in that world but instead in a reality with usual learning by experience. 
The art of self-care is partly due to the ability to learn, but also the experiences stored within 
us and the ability to transform it to a beneficial action. Habits are usually created early in life 
and it takes time to develop or change of a habit into something else. Usually it needs motiva-
tion to make a lifestyle change happen. That is where we in health-care have a role as motiva-
tors to those who seek knowledge and skills to make a change towards an increased self-care. 
With an increasing aging population, it will be an expanding number of persons suffering 
from heart failure (HF) often in combination with multi-morbidity. Many of these persons 
will look for symptom alleviation, seek knowledge and have a wish of participating in their 
own self-care. To improve outcomes by increased self-care in the growing population of 
persons with HF afflicting more than 38 million people in the world today is extremely val-
uable (1, 2). It has been estimated that the prevalence of HF will increase with 46% from 
2012 to 2030, just to underline the magnitude and the urgent need for interventions to sup-
port self-care (3). This thesis aimed to study innovative approaches to new and old methods, 
with special focus on supporting self-care and wellbeing in persons with HF. It was made 
through testing an invention of a technological mobile health (mHealth) system and evaluated 
its effects on self-care, HRQoL, knowledge, adherence and hospitalization. Further through 
exploring the experiences from the persons with HF using the mHealth system. This thesis 
also wanted to evaluate HRQoL, physical exercise, depression and anxiety by the perfor-
mance of yoga and hydrotherapy. 
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2 HEART FAILURE 
HF can be defined as a functional or structural impairment of the heart. This will result in 
reduction of the ability to deliver oxygenated blood corresponding to the requirement from 
metabolizing tissues of the body. Further, a reduced cardiac output and/or elevated cardiac 
filling pressures will appear during exercise but also in a resting condition. As a compensa-
tion to maintain sufficient cardiac output there is an activation of neuroendocrine hormones 
that includes the Renin-Angiotensin-Aldosterone system together with the sympathetic 
nervous system (4). 
2.1.1 Etiology, epidemiology and prognosis 
In Sweden, the prevalence is estimated to be around 2-3 %. At the age of 75 years and 
older, about 10 percent of the population has HF (5, 6). Two percent of Sweden's total 
healthcare costs are related to HF and 75% of the costs are caused by hospitalization (5). 
The reasons for acute hospitalization for HF are varied, ranging from poor understanding of 
disease management, dietary, weight monitoring and non-adherence to medical therapy. 
The reasons can also be a failure to seek medical attention in time due to worsening HF by 
e.g. comorbidity of myocardial infarction, atrial fibrillation or anemia (7, 8). The most com-
mon causes of HF are related to ischemic heart disease and hypertension (6), valvular heart 
diseases and rhythm disorders such as atrial fibrillation (4, 5). HF is associated with a poor 
outcome including both high mortality and morbidity together with impairment and an ex-
ceptionally reduced HRQoL. One-year mortality is approximately 20-30%, while after five 
years it is around 50-65% (4). The long-term mortality rate for HF after diagnose has de-
creased in Sweden over the past two decades, but mortality remains high especially for per-
sons who need frequent medical care, which is associated with a very poor outcome (9).  
2.1.2 Diagnose 
A correct diagnose of HF and its etiology is very important and can be a challenge partly 
due to the unspecific symptoms and signs of HF (4). It is particularly difficult to detect 
early symptoms in elderly persons and those with obesity (10) but also among those with 
chronic obstructive pulmonary disease (11). There should be both symptoms and clinical 
signs together with a verification of impaired cardiac function through an echocardiography 
to confirm the diagnose (4). The echocardiography (ECHO) provides information about the 
anatomy and function of the heart, together with valvular function and estimation of the 
ejection fraction (EF). EF is the objective indicator of how well the heart is able to pump 
the blood throughout the body but is also an important prognostic marker (12). According 
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to European guidelines today (4), there are three different categories of HF. In the first cate-
gory, the heart has reduced power of contractility, detected through reduced EF <40% and 
is called heart failure with reduced ejection fraction (HFrEF). The second category of HF 
has a preserved power of contractility with normal EF >50% but with reduced capacity to 
relax the heart and receive blood from the body and is called heart failure with preserved 
ejection fraction (HFpEF). A third category heart failure with midrange ejection fraction 
(HFmrEF) was recently formed as a distinct own category with the EF range between 40-
49%. The new category should also have evidence of relevant structural heart disease such 
as left ventricular hypertrophy or left atrial enlargement, or signs indicating diastolic dys-
function. To be diagnosed with HF in one of the three categories, the persons should have 
blood samples with elevated levels of B-typical natriuretic peptides as well as symptoms 
and signs of HF (4). Another important investigation concerning HF is Electrocardiogram 
(ECG) which can give a picture of signs of hypertonia, previous myocardial infarction or 
rhythm disorders. A normal ECG means most likely that there is no HF (13). In summary, 
clinical findings, abnormal ECG or elevated B-typical natriuretic peptides levels are not 
enough to diagnose HF. ECHO of the heart is necessary where the size, pumpability, filling 
pressure, and appearance of the valves can be assessed (4). 
2.1.3 Symptoms, clinical signs, NYHA class and comorbidity 
Symptoms are defined as experiences of illness from a subjective point of view reflecting the 
persons reality (14). The most common symptoms of HF are shortness of breath, exercise in-
tolerance, fatigue, and ankle swelling (4). The symptoms in HF reflects the personal func-
tional status and are classified into four stages based on symptom severity and how limited 
the person is during PA with respect to fatigue and shortness of breath and is related to self-
care (15, 16). The reduced exercise tolerance is defined as New York Heart Association 
Classification (NYHA). Table 1 gives an overview of the most common symptoms of HF 
and what impact they have. NYHA classification places the person in one of four categories 
based on how limited they are by their symptoms during physical activity or during rest 
(17). Simultaneously there can be a multiple experience of combined symptoms and signs 
in HF (18). Three distinct symptom clusters are identified by Yu, Chan (19), distress clus-
ter (including shortness of breath, anxiety, and depression),  decondition cluster (fatigue, 
drowsiness, nausea, and reduced appetite), and discomfort cluster (pain, and sense of gener-
alized discomfort). These clusters accounted for 63.25% of variance of symptom experi-
ence identified in persons with HF. All tree symptom clusters independently predicted the 
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health related quality of life (HRQoL). Together with these symptoms there are usually dif-
ficulties in sleeping (20) together with reduced exercise tolerance and cognitive impairment 
(4, 19, 21). 
Table 1. New York Heart Association of functional classification (NYHA) measuring 
symptoms/signs of fatigue, dyspnea and palpitations. 
 
Signs in HF are defined as objective biological changes by disease with the possibility to 
detect through different procedures like biomarkers and x-ray (14). Typical signs can be el-
evated jugular venous pressure and pulmonary crackles (18). Symptoms and signs may in-
crease for several weeks, months or sometimes develop unexpectedly rapid, forcing the per-
son to seek emergency care (18). It is very common in HF with comorbidities, defined as 
multiple concurrent conditions of other common diseases that also require active manage-
ment (22-24). Comorbidity in HF is associated with increased age and there is a significant 
relationship between self-care and the numbers of comorbidities (25). There is considerable 
comorbidity among persons with HF together with ischemic heart disease, hypertension, di-
abetes and chronic obstructive pulmonary disease (26). 
Class Symptoms 
NYHA I:  No limitation of physical activity. Ordinary physical activity does not 
cause symptoms/signs 
NYHA II:  Slight limitation of physical activity. Comfortable at rest. Ordinary 
physical activity results in symptoms/signs 
NYHA III:  Marked limitation of physical activity. Comfortable at rest. Less than 
ordinary activity causes symptoms /signs. 
IIIa the person can walk> 200 meters 
IIIb the person can walk< 200 meters  
NYHA IV:  Unable to carry out any physical activity without discomfort and 
symptoms/signs during rest. 
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2.1.4 Health related quality of life 
HRQoL has been identified as a clinical key indicator to predict morbidity and mortality in 
HF (12). Poor HRQoL is the strongest independent predictor of total healthcare consumption 
and costs. Healthcare costs in chronic HFrEF are at least two-fold higher than in the general 
population (27). Persons with HF experience a great impact on their HRQoL regarding physi-
cal reduction, but also depression and anxiety. HRQoL is a way of measure dimensions of 
life in relation to the person´s reaction to his/her illness. The WHO definition of HRQoL con-
sists of three components physically, mentally and social. It is of great importance to identify 
person-centered problems with measurements to improve the understanding of a problem and 
the person´s subjective experience. Behaviors like genetic inheritance, and social factors 
throughout the life course appear to be more strongly correlated with the physical functioning 
and HRQoL in persons with old age (28). Highly prevalent impairments are not by definition 
perceived as severe by the person with HF and do not always contribute to the overall 
HRQoL. These insights are important in providing optimized, individualized care for persons 
with HF (29). Psychological distress, poor health perception, higher NYHA grading and 
lower education level are all identified as significant factors associated with around 50% 
poorer HRQoL (30). A recent review identified key factors associated with HRQoL and pre-
sented depression as the most frequent related factor leading to a worsening HRQoL, fol-
lowed by a higher NYHA class, younger age and female gender (31). The measurement of 
health and sickness and the effects of the disease but also the impact of healthcare include an 
indication of change. The change is usually measured before and after treatment and esti-
mates the perception of HRQoL and include the disease frequency and severity. Two basic 
categories of instruments are commonly used for different purposes and circumstances to 
measure treatment effects important to clinical management considering HRQoL. The first 
category contains generic instruments like Short-Form 36 (SF-36), and Euro quality of life 5 
dimensions (EQ-5D) (32, 33), which are multidimensional and have an attempt to measure 
the core dimension of HRQoL by capturing the physical, mental, and general health, vitality 
and social condition. However, they may fail to capture small special effects within a disease 
and do not always respond to changes in specific conditions (34). The second category of in-
struments are those that focuses on these distinct aspects specific to the area of HF. These in-
struments are disease specific like Minnesota Living with Heart Failure Questionnaire 
(MLHFQ) and Kansas City Cardiomyopathy Questionnaire (KCCQ) (35, 36) and are some-
times perceived as more relevant than generic measures because of their ability to capture re-
sults and risk of deterioration and improvement through e.g. the symptoms in order to get an 
understanding of the individual’s experiences living with the disease (36). 
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2.1.5 Treatment 
Treatment goals in HF are reduction and facilitation of symptoms and signs, decrease hos-
pitalization as well as improved survival. Furthermore, there is a conscious aspiration to im-
prove HRQoL (2, 4). The European Society of Cardiology (ESC) has identified a standard 
care that everybody with HF should have access to, which involves basic treatment with ad-
equate drugs, consideration of cardiac resynchronization therapy, advices of physical activ-
ity (PA) and good self-care (4, 37). The pharmacological treatment in HF is complex with a 
combination of medications and treatment-self-care strategies in an individualized composi-
tion simultaneously striving for optimal doses. Basic pharmacological treatment is angio-
tensin converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB) as al-
ternative if intolerance to ACEI together with beta-blocker and mineralocorticoid receptor 
antagonist (MRA). Together with these medical treatments, different doses of diuretics are 
given to relieve symptoms and signs of congestion (4). Sacubitril/valsartan is a new availa-
ble drug for the treatment of HF that may replace ACEI and ARB (38). If the person still is 
suffering from severe HF together with prolonged QRS duration, a cardiac resynchroniza-
tion therapy (CRT) may be beneficial (39) alone, or together with an implantable cardio-
verter defibrillator (ICD) that can deliver an electrical shock to the heart when life-threaten-
ing rhythm disorders are detected (4, 40). Today it is common that a person with newly diag-
nosed HF is offered to come to a HF outpatient clinic. Pharmacological and self-care strate-
gies are often given together with a multidisciplinary HF team, consisting of cardiologists and 
nurses, with access to a physiotherapist, dietician and social counselor (4). Jaarsma and 
Stromberg described the need for nurse-led HF-clinics based on nursing and reflected on the 
development over time with HF clinics as an important role in supporting persons with HF in 
self-care. Previously, it has been observed that follow-up visits to a HF clinic after hospitali-
zation, improved survival, reduced number of hospital days and increased self-care (41, 42). 
An important addition to the aspect of care is person centered care (PCC) focusing on health 
and resources rather than disease and limitations. The model of PCC starts from the narrative 
of the person with HF and their view of illness and health and develop a partnership based on 
the co-relation with a personal health-plan (14). 
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3 SELF-CARE  
Self-care is defined as a naturalistic decision-making (NDM) process addressing both the pre-
vention and management of chronic illness, with the core elements of self-care maintenance, 
self-care monitoring, and self-care management (2). It is considered essential in chronic ill-
ness and practical recommendations for HF states the importance of support for self-care (4, 
43). The self-care process is essential in the management of both health and illness through-
out life (44). Self-care starts with individual responsibility, in making daily choices about pre-
ferred lifestyle. It is also a definition made by the WHO´s Self Care Forum as ”actions that 
individuals take for themselves, on behalf of and with others in order to develop, protect, 
maintain and improve their health, wellbeing or wellness” (45). Even if the definition can be 
expanded, to a process of maintaining health through health-promoting practices and manag-
ing illness (46) within that, there are a lot of circumstances that influences the performance of 
self-care. Self-care is a broad concept in which the person's behaviors affects the process re-
garding medication, diet, immunization, PA and the implementation of other lifestyle changes 
that correspond to the self-care recommendations to support an increased self-care mainte-
nance (45, 47). There are underlying processes that make self-care complex, as the need for 
decision-making and always weighing thoughts, values and actions before choosing an ap-
proach (2, 43, 46). The choice of decision and behavior aims to maintain balance towards 
physical and mental stability and respond to symptoms and signs when they occur (43). Fur-
ther, self-care is what persons do for themselves to establish and maintain health, prevent and 
treat illness which is dependent on many factors. Self-care is known to be affected by interac-
tion of age, gender, cognitive ability, depression, NYHA class, HRQoL, socioeconomic fac-
tors as well as education. In the same time self-care is also based on values, past experiences 
and habits as well as the person's ability to use his / her knowledge and acquire new 
knowledge (16, 48). The very valuable source of interaction with family support is not to be 
forgotten in relation to self-care (49). In the guidelines of ESC there are advices on subjects 
that a person with HF needs to know about their sickness. At the same time, there are a lot of 
circumstances to consider affecting the possibility to carry out and implement self-care (37). 
3.1.1 Self-care theories 
A theory can be defined as a logical set of verified relationships useful for explanation and 
prediction and thus for control (50). It is designed to describe a situation, explain how ele-
ments are related to each other in a specific situation, and can make predictions about the fu-
ture. The self-care process has been investigated since the 1980s (44, 51) and has revealed as 
an extremely important part of a successful management of HF (2, 4, 43, 46). Based on 
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Orem's nursing theory (44), other self-care theories has been developed (46, 51), focusing on 
how specific clinical phenomena can be seen and understood in practice of HF like for exam-
ple ”the situation specific theory of heart failure self-care” (43). 
3.1.2 Natural decision making 
The Naturalist decision making (NDM) is defined as a fundament to self-care, a way that eve-
rybody use their experiences to make decisions, but proper self-care can also be obtained 
through learning (47, 52). The NDM process reflects the complex and multifaceted procedure 
of the reality in life, were situations consists of an automatic, impulsive context (53). The 
NDM tries to understand the ability of humans and how a decision often involves uncertainty, 
time stress, misunderstanding information and dynamically changed conditions. It also affects 
the interaction between persons, by being situation specific towards the individual’s prob-
lems. NDM is also influenced by individual experiences as well as interaction between envi-
ronmental factors such as education and socioeconomic factors (43, 47). 
3.1.3 Self-care maintenance 
The first part of the self-care process captures treatment adherence and healthy behaviors 
(43). A valuable aspect in the whole self-care process is this first category self-care mainte-
nance, which is known to improve HRQoL, increase exercise capacity and reduce hospitali-
zation and mortality due to outcome results (2, 54-56). To achieve maintenance, motivation 
and knowledge, together with effort are required to maintain optimal health in the best way, 
despite suffering from a disease. The changes may involve a lot of new medications pre-
scribed. Other self-care behaviors in the process of maintenance is weighing daily, PA, im-
munization, to reflect on fluid intake, salt-restriction, managing stress, healthy heart-diet, 
smoking/ nicotine cessation together with how to handle alcohol (43, 46, 57). These self-care 
behaviors should be encouraged in order to make improvements in well-being but also to 
maintain health together with physical and emotional stability (43). The activities in the pro-
cess of self-care can be chosen by the person him/her self to achieve created goals but also 
with the help of others, such as healthcare professionals or caregivers like partners/family. 
3.1.4 Symptom-monitoring  
The second part of the self-care process starts with symptom perception as a part of symptom 
monitoring. Symptoms can be defined as a feeling of an abnormal experienced inner condi-
tion (53). The monitoring part involves body listening, detection, evaluation, interpreting the 
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meaning and labeling both symptoms and signs (43, 58). A reasonable action must be possi-
ble in response. The objective of monitoring symptoms and signs is according to Riegel and 
Jaarsma a recognition that a change has occurred (46). 
3.1.5 Self-care management 
Self-care management is the part of the self-care process when the response to impairment of 
HF symptoms and signs may occur. This third part requires ability to manage symptoms and 
signs of deterioration, recognition of the change, but also to be aware of what action should 
be taken and how to handle it. If response is needed, self-care management involves the im-
plementation of treatment together with an evaluation, so that the approach can be re-exam-
ined in the future (43, 46). All of the three parts in the self-care process are being influenced 
by both autonomous and advisory elements within the NDM process, affecting how a deci-
sion is created through influence by knowledge, skills, experience and values (43). 
3.1.6 Self-care confidence 
Self-confidence is known to moderate and mediate the relationship between self-care and out-
come (43). Cognition affects self-care behaviors in the process indirectly, trough self-care 
confidence and interventions aimed to improve self-care confidence may improve the self-
care process, even in persons with impaired cognition (59). Reflection or contemplation is 
linked to knowledge acquisition (60). Factors associated with self-care behavior are self-con-
fidence, functional capacity, knowledge, health literacy and social support. The purpose of a 
study with 321 persons with HF was to explore factors associated with self-care behaviors 
and to examine the mediating role of self-care confidence. Associations found were that 
health literacy and social support were directly related to self-care maintenance. The results 
also showed that functional capacity and knowledge were directly associated with self-care 
management. Moreover, self-care confidence mediated the relationships between knowledge, 
health literacy, social support and self-care behaviors (61). Self-confidence both moderates 
and mediates the relationship between self-care and outcome (43) and there is a knowledge 
that cognition affects self-care behaviors indirectly, trough the influence of self-care confi-
dence. The result of improving self-care confidence may improve self-care, even in persons 
with impaired cognition. Self-efficacy can be involved as a mediator between effective self-
care and self-confidence (59). Self-care confidence and information about maintenance and 
management of HF can give greater control of the health and encourages healthy behaviors 
which in the long term will prevent deterioration. In many cases persons can take care of their 
minor ailments, and by doing so reducing hospitalization (45).  
 10 
 
3.1.7 Factors influencing self-care 
The self-care process has an overall significant impact on symptoms, well-being, prognosis 
and morbidity (37, 51, 62). Self-care in HF is affected by interaction of many different known 
factors such as age, gender, cognitive ability, depression, NYHA class, HRQoL, socioeco-
nomic factors as well as education. In the same time the self-care process is also based on val-
ues, past experiences and habits as well as the person's ability to use his / her knowledge but 
also the dedication and effort of acquiring new knowledge (16, 48). The persons with HF are 
advised to take medication, follow restrictions, weighing, monitor symptoms and signs and 
manage their symptoms / signs in case of deterioration and perform a measure, followed by a 
proper evaluation (63). At the same time, they are also advised to maintain an optimal healthy 
lifestyle with for example PA and healthy diet. Poor adherence to HF recommendations is as-
sumed to be responsible for approx. 50% of acute admissions to hospital due to deterioration 
of HF (64). Follow-up of both medical and non-medical treatments are crucial both for clini-
cal survival and HRQoL.  
3.1.8 Values motivation and culture 
Self-care is influenced by cultural beliefs, including the meaning ascribed to HF, and by so-
cial norms. A common belief from the persons with HF is that the sickness is inevitable or at-
tributed to stress. There is also a belief from the afflicted persons that there is a spiritual link 
affecting the self-care concept in a way that prayers are believed to have an effect. Cultural 
beliefs have been supported by self-care behaviors like medication adherence. Cultural pref-
erences can also affect the food choice even if salt-restricted diet is advised (65). A review of 
19 qualitative research studies of a conceptual model of attitudes, beliefs, and expectations of 
persons with HF, showed that persons experienced a sense of disruption before developing a 
mental model of their sickness HF. The reactions when being diagnosed with HF includes be-
coming a strategic avoider, a selective denier, a well-intentioned manager, or an advanced 
self-manager. Persons with HF responded by forming self-management strategies and finally 
assimilated the strategies into everyday life seeking to feel safe (66). 
3.1.9 Depression and cognitive ability 
A substantial proportion of persons with HF have concomitant cognitive problems. The prev-
alence of cognitive impairment in HF is around 43% (n = 26 studies, 4176 participants) ac-
cording to a review of 26 studies (67). From a mental point of view depression is one of the 
most common causes of ill health and disability. Both depression and anxiety together with 
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impaired cognition are factors that affect perceptions and wellbeing in persons with HF (68). 
Depression has been detected in 13.9 to 77.5% in persons with HF (69-71). It is believed to 
be in such wide range due to multiple of symptoms simultaneously. Those with concomitant 
depression have two to three times higher mortality (72) and depression is considered to be an 
independent risk factor for mortality in HF (68, 69). Depression also has a significant preva-
lence with contributions to the overall poor disease specific HRQoL (73) by a strong relation 
to physical symptoms (74). 
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4 M-HEALTH TO SUPPORT SELF-CARE IN HEART FAIL-
URE 
Today in society there is a trend towards increased use of technology in different combina-
tions and forms. Partly due to the results of reducing morbidity and mortality in some of the 
studies, but also the improvement seen in self-care and HRQoL (4, 75). Although the re-
sults are unclear and as there are several types of mHealth and most are enrolled in multi-
disciplinary care management programs, each approach needs to be assessed on its individ-
ual merits.  
A goal worldwide is to enhance the self-care process in persons with HF due to its major 
importance on outcome (37, 76). Technology in health care is an application for control and 
learning more about a disease together with health topics (75). There is a huge interest in 
technology with a comprehensive overall concept, eHealth concerning information and 
communication technology (ICT) (77). 
4.1.1 What is mHealth? 
The concept mHealth represents a novel intensified follow-up strategy of HF management 
and may play a crucial role in early detection of HF progression and may improve outcome of 
persons with HF (78). A subdivision to ICT is mHealth including telehealth and telemoni-
toring. mHealth covers a broad spectrum from “mobile devices or hand-held computers 
such as mobile phones, laptops, tablet or PDAs, which can be used for text, voice or image 
communication, and can collect, process and report data”(77). Within the mHealth concept 
remote monitoring with or without transmission of physiological data is gathered. ECG, 
blood pressure, weight, respiratory rate and other self-care, educational or lifestyle advices 
are examples of such data. The information gathered can be stored within the technical de-
vice or transmitted to the healthcare by broadband, satellite, wireless or blue tooth (77, 79). 
mHealth can be used by the person himself who is suffering from a disease or in collabora-
tion with the health care system or caregivers (75, 77). mHealth offers the person assistance 
in self-care, medical adherence and knowledge of when it is time to visit the healthcare 
(75). Even though two meta-analyzes concluded positive results for mHealth showing a 
34% decrease in mortality, together with a reduction of HF-related hospitalizations by 35-
56% (80, 81) the difficulty in understanding and maintaining self-care behavior remains. It 
is still unclear whether the technological aids could provide concrete benefits for the self-
care process in persons with HF and also in what form it should be delivered (77). There 
are a lot of circumstances that affect the abilities to perform and enhance self-care trough 
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mHealth (37, 82). Up to date the impact of the mHealth-based HF interventions on HF-re-
lated outcomes are mixed (83). A newly published review of nine studies where six were 
randomized controlled trials, illustrated the impact of mHealth interventions on all-cause 
mortality, cardiovascular mortality, HF-related hospitalizations, length of stay, NYHA 
class, left ventricular ejection fraction, HRQoL, and self-care showing the overall impact on 
current mHealth as inconclusive which underscore the need for further research to enhance 
the self-care process (83).  
4.1.2 Adherence to mHealth and the self-care process  
Adherence to the use of the mHealth system is usually high, demonstrated by Seto and 
Leonard (84) with 70% of IG who completed at least 80% of their possible daily readings. 
Hoban and Fedor observed that adherence with weighing after six-months follow-up was 
the same in IG with mHealth and CG(85). Boyne and Vrijhoef also reported that daily 
weighing improved after three months together with fluid intake but also daily PA. Adher-
ence to medication increased after six and 12 months but no effects on diet, smoking and 
alcohol consumption occurred (63). Lynga and Persson also observed in their study that the 
average personal adherence to daily weight was high in IG with mHealth. Persons with ad-
herence > 60% to daily weighing were hospitalized less than persons with <60% adherence 
for cardiac event, although this was not statistically significant (86). In a pilot-study of Ar-
tinian and Harden the persons in the IG group had high adherence to medication, which 
turned out to be 94% (87). Their study with mHealth also showed 81% daily blood pressure 
measurement and 85% adherence to daily weight in comparison with CG group. Ramaekers 
and Janssen-Boyne observed in their study of adherence that fluid retention, daily weigh-
ing, physical exercise and alcohol restrictions significantly improved in IG with "Buddy 
mHealth" compared to CG. Medical adherence showed no significant difference in the RCT 
of the three groups studied by Wakefield and Holman neither at three or six months follow-
up time (88). In Boyne and Vrijhoef study (63), self-care measured by EHFScBs was im-
proved by mHealth, while no changes were made to persons receiving common care. On 
the other hand, in Bowles and Riegel study, there was no significant effect on self-care 
compared to standard home care measured by Self Care HF Index regarding self-care 
maintenance, self-care management or self-confidence with respect to HF self-care (89). 
Improvement for both IG and CG was seen within groups comparison of both self-care 
maintenance and self-care management in Seto and Leonards (5) study, while self-care 
maintenance was more enhanced in IG. A multicenter study (n=314) with mHealth evalu-
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ated by EHFScBs a significant difference in self-care was between IG and CG (90). Ar-
tinian and Harden performed a small RCT pilot-study with 18 persons with HF using the 
EHFScB scale looking at self-care behavior and detected no differences between IG and 
CG after three months using mHealth (87). Hoban and Fedor detected after 90 days a sig-
nificantly improved self-care management between IG and CG. After 60 days, an increase 
in PA was observed, which was not seen after 90 days (85). In the study by Dansky and 
Vasey (91) the IG group with "Buddy mHealth system" was evaluated and significant im-
provement was detected in 5 of the 8 self-care areas. The five areas were flexible diuretics 
in breathlessness, flexible diuretics in edema, flexible diuretics at weight gain, daily weight 
and current weight. IG and CG showed no differences between groups concerning current 
salt intake, filling in doses with medication and adherence with medication. Benatar and 
Bondmass had also evaluated the mHealth system "Buddy mHealth" in a RCT study. Care 
was delivered by the home nurse visit or nurse visit+mHealth. Differences was discovered 
in the use of salt in cooking with a decrease for those using mHealth (92). 
4.1.3 mHealth and self-confidence  
Self-esteem in HF, measured with Efficacy expectation scale in 382 persons with usual care 
in CG compared to IG with mHealth, showed significant improvement at six months in IG 
but not after 1 year (63). Also in the study by Benatar and Bondmass, self-esteem was 
measured but by the Self-efficacy scale in being able to feel safe in managing the disease of 
HF, a significant increase was demonstrated in the IG group receiving mHealth (92). Sev-
eral studies (93, 94) explore the "Buddy mHealth system” using the Efficacy expectation 
scale regarding self-esteem in HF disease management and reported significant differences 
between IG and CG. Wakefield and Homan (88) had three groups of persons with HF in 
their RCT study, a telehealth group, a video group and a standard CG. There were no sig-
nificant differences between the three groups studied with two of the instruments that fo-
cused on self-esteem and symptom-monitoring. 
4.1.4 mHealth and disease-specific knowledge 
Disease-specific knowledge was significantly higher in IG than CG in a multicenter study 
evaluating mHealth (n=314) (90). This was also seen in the study of Boyne and Vrihoef 
where HF knowledge improved significantly between CG and IG using mHealth (63). 
Delaney and Apostolidis (95) saw that both CG and IG with mHealth increased their 
knowledge in HF from baseline to 90 days. Wakefield and Holeman could not detect any dif-
ference in measuring the disease-specific knowledge between IG and CG with mHealth (88). 
On the other hand, Ramaekers and Janssen-Boyne could measure an improvement that was 
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significant in disease-specific knowledge in two of the three hospitals where the study was 
conducted, using mHealth (96). 
4.1.5 Barriers to mHealth 
Barriers to mHealth are described as, lack of immediate benefit in using the mHealth sys-
tem, the mixtures of symptoms related to comorbidity in elderly, compatibility and per-
ceived lack of security. Further, the need of simple usable technology together with training 
due to lack of computer skills and low self-efficacy. Other limitations mentioned are forget-
ting to use, concentration problems, and visual or cognitive limitations in elderly (57, 97, 
98). There are other barriers from the health organization and professional point of view 
due to conflicting evidence but also the time and education issue in building new experi-
ences to work efficiently with mHealth (57). 
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5 PHYSICAL ACTIVITY AND SELF CARE 
Physical activity is an important part of self-care and there is a great interest to improve and 
intensify PA in persons with HF (2). New physical training methods to increase and individu-
alize PA, based on personal preferences are needed for improvement. Today there is a com-
mon knowledge that low PA contribute to lower capacity found in persons with heart diseases 
(99). HF-action, the largest randomized controlled trial to date on PA in HF (n=2331) showed 
a modest improvement in exercise capacity and mental health in those who were physically 
active. The adherence to the prescribed regimen of PA after three years was only 30% (100) 
which strengthens that alternative forms of PA are needed. 
5.1.1 Definition of physical activity 
PA can be defined as “any bodily movement produced by skeletal muscles that results in en-
ergy expenditures” and is highlighted as a key component to enhance the experience of well-
being. PA can either be classified as structural or incidental. Structural activity or exercise is a 
planned and purposeful activity to promote health and fitness benefits. Incidental activity is 
PA that are unplanned (101). When assessing PA there are four dimensions included in the 
concept. First dimension is mode or type of activity in which a description of type of activity 
performed e.g. waking, gardening, cycling etc. should be made. It can also be defined in the 
context of physiological and biomechanical demands/types e.g. aerobic versus anaerobic ac-
tivity, resistance or strength training, balance or stability training. Second dimension include 
the frequency in number of the performed activity. Third dimension defines the duration in 
time of the performed activity. The fourth and last dimension is the intensity in rate of energy 
expenditure of performed activity. It is an indicator of the metabolic demand of an activity 
(102). Summarizing, the goal when presenting PA is to identify the frequency, duration, in-
tensity, and types of activity performed during a time-period range from a few hours to a life-
time (103). In addition to the dimensions are four common domains in which the PA occurs, 
central for understanding behavior change in assessment of PA. First domain is occupational 
e.g. carrying or lifting objects at work. Second domain is domestic e.g. housework, yardwork, 
childcare, self-care, shopping, incidental, transportation and leisure time. Third domain 
named transportation include e.g. walking, bicycling or climbing. The last and fourth domain 
is leisure time e.g. sports, hobbies, exercise (102).  
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5.1.2 Benefits of physical activity 
Measures of PA can be assessed subjectively by self-reports as questionnaires and diaries. Di-
rect measures can be made with objective methodologies like motion sensors such as accel-
erometers, pedometers, heart-rate monitors, and multiple-sensor devices. There are also dif-
ferent methods used to quantify energy expenditures. Relative intensity of PA can be deter-
mined in relation to exercise capacity like peak VO2, percent of peak heart rate or six-minute 
walk test (6MWT) (102). Engaging in PA during life has many benefits, including increasing 
life-span. A recent pooled analysis of large longitudinal studies found that persons who en-
gaged in 150 minutes per week of PA at moderate intensity had a 31% reduction in mortality 
compared with those who were less active with the greatest benefit for those older than 60 
years (104). PA has multiple other benefits in older age including improved physical and 
mental capacities. There is a 50% reduction in the relative risk of developing functional limi-
tations among those reporting regular and at least moderate-intensity PA. The benefits known 
by increased PA are improved cardiorespiratory and muscular fitness/strength, bone and 
functional health, maintained cognitive function, reduction of anxiety and depression together 
with improved self-esteem (105-107). PA also appears to preserve, and may even improve, 
cognitive function in persons without dementia (105, 108) together with reduction in cogni-
tive decline by around 30% (109). Yet, despite the clear benefits of PA, the proportion of the 
population meeting recommended levels falls with age, and analyses of data from SAGE and 
the WHO World Health Survey suggest that around one third in age 70–79 and one half of 
persons aged 80 years or older fail to meet basic guidelines for PA (110).  
5.1.3 Recommendation of physical activity 
Persons are considered physical active if they perform more than 30 min/d of PA with mini-
mum modest intensity, equivalent to approximately 10000 steps/d. according to Tuder-Locke 
and Basset criteria (111, 112). According to the WHO, PA for adults aged 65 years and above 
are recommended for at least 150 minutes of moderate PA peer week or 75 minutes of vigor-
ous PA. The activity should be performed in periods of at least 10 minutes duration. There is 
a dose-response relationship which increases with PA time. In addition, muscle-strengthening 
activities, involving major muscle groups, should be done twice a week. Older with poor mo-
bility, are advised to add activity to enhance balance and prevent falls three days per week. 
PA should always be encouraged within the framework of abilities and conditions (107) also 
strengthened by Wahid and Manek (113) suggesting that the greatest health-benefit is associ-
ated with moving from inactivity to small amounts of PA. A total of 36 studies (n=3 439 874) 
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and 179 393 events, during an average follow-up period of 12.3 years were included in that 
analysis. 
5.1.4 Exercise training  
Exercise as a therapeutic intervention is defined as “physical activity that are performed re-
petitively to increase the performance capacity of the cardiovascular system (aerobic exercise 
training) or muscular skeletal system (resistance exercise training)” (54, 101). Even moder-
ate exercise training shows significant improvements in self-reported health status with 
KCCQ measuring disease specific HRQoL compared with usual care without training. Im-
provements shown in the study by Flynn, Pina (100) occurred early and persisted over time 
performed with 2331 medically stable persons with HF. In HF physical exercise training is a 
part of self-care and is well established and documented with recommendations in guidelines 
(4, 114). Results from systematic reviews and meta-analyses have shown that exercise train-
ing is not only safe but also associated with reduced risk of hospitalization and decrease in 
mortality (55, 56). Many randomized controlled trials have shown similar benefits (105, 115) 
with  progressive resistance training and may give independent benefits (116) together with 
benefit in HRQoL for persons with HF (117). 
5.1.4.1 Muscle strength, endurance and balance 
Interventions to promote muscle strength and endurance have also been shown to be effective 
for improving physical functioning in older people, including improved strength (116). All 
domains of PA and exercise training are essential for the older population such as aerobic, 
strength and balance. Aerobic exercise are well investigated, however new evidence shows 
that progressive resistance training (RT) has favorable effects not only on muscular strength 
but also on physical capacity and the risk of falls (116). These benefits can be extended to 
cardiovascular function, metabolism and coronary risk factors (17) for those with or without 
cardiovascular disease. In a study by Giuliano and Karahalios with RT as a single interven-
tion they found increase in muscle strength, aerobic capacity and HRQoL in persons with HF 
(118). RT may offer an alternative approach, particularly for those unable to participate in 
aerobic training. The effect of RT on muscle strength is mainly during slow controlled move-
ments (118). Aerobic training has shown reversed left ventricular remodeling in clinically sta-
ble persons with HF but this benefit is not confirmed with combined aerobic and strength 
training (119). Anyhow, endurance training with or without strength training is recommended 
for clinically stable persons with HF and is associated with an improvement in peak VO2, 
muscle strength and HRQoL. It also reduces overall and disease-specific hospitalizations (54, 
120, 121). In a study performed by Davis et al. 3647 persons with HF, mainly male, with 
  19 
low-to-medium risk, and NYHA class II-III with a EF of <40% were compared with usual 
care. Exercise training reduces HF-related hospitalizations and resulted in clinically important 
improvements in HRQoL. Concerning HF medication it should be optimized with the aware-
ness that ACE inhibitors have a moderate positive effect on the working capacity (122). An 
increase in work capacity and EF both in rest and after exercise is expected with the treatment 
of beta-blockade (123).  
Hydrotherapy improves exercise capacity as well as muscle function in small muscle groups 
in persons with HF together with increase in HRQoL. Hydrotherapy has shown a general in-
crease in early diastolic filling accompanied by a decrease in heart rate, leading to an increase 
in stroke volume and EF (124-127). Today hydrotherapy is implemented as an alternative to 
physical exercise training in standard HF care in the Swedish population (128).  
5.1.5 Adherence to physical activity 
The WHO 2015, definition of adherence is the extent to which a person’s behavior—medica-
tion, following a diet, and/or executing lifestyle changes-corresponds to the recommendations 
of a healthcare provider. Non-pharmacological treatment of HF includes self-care education 
for the person with HF together with the family or caregiver. To be adherent to medication, 
PA, vaccination, fluid restriction and daily weight often requires an effort by the individ-
ual/person with HF (37, 57, 86, 102). Five dimensions that affect adherence consists of social 
and economic factors, factors related to the health care system, to the condition of the person 
and the therapy (129). Analysis has showed that self-efficacy and cardiovascular risk factors 
are related to adherence (93). A correlation with adherence and factors regarding marital sta-
tus, education and income, related to self-care results have arisen in other studies (82). Adher-
ence to physical exercise in HF is around 50% (100, 130, 131). Non-adherence to exercise 
recommendations has effects on clinical outcome such as increased HF readmission and mor-
tality (129, 130). In addressing adherence to application of exercise recommendations there 
are aspects that need consideration, like the adherence to self-care PA advices, but also health 
care providers adherence to clinical guidelines (132). Exercise adherence is the extent to 
which a person acts in accordance with the advised interval and exercise dosing regimen 
given (102, 103). Various management programs aimed to optimize self-care in HF have 
been launched and evaluated, but still there are difficulties to comprehend and maintain self-
care in PA recommendations. Despite PA being safe, effective, and a guideline-recom-
mended treatment to improve HRQoL, exercise training remains underutilized. Both the per-
son him/herself, the practice and environmental barriers need to be addressed to improve this 
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quality gap (4, 114). Older age, a low level of education together with socioeconomically dis-
advantaged are known factors influencing adherence to rehabilitation and PA in general (133, 
134). To perform regular PA throughout the whole life requires motivation and effort. Per-
sons with HF is known to have positive outcomes such as improved physical capacity and 
HRQoL, and reduced health care utilization with regular exercise training (132). Exercise 
limitation is characteristic in HF and increasing degree of intolerance is associated with poor 
prognosis (130). There are a lot of circumstances that correlates in different ways to low PA 
in adults, like demographic and biological factors, psychological, cognitive and emotional 
factors. Also, behavior attributes and skills, social and cultural, together with physical envi-
ronmental factors (110, 135). 
5.1.6 Barriers to physical activity 
Some of the factors influencing PA concern personal factors, lack of time, knowledge, and 
motivation (106, 110). Physical appearance concerning fatigue, anxiety/depression (130) or 
comorbidities (136) but also the cost of exercise facilities influences PA. Higher NYHA clas-
sification and a lower self-efficacy are other factors associated with less daily PA (111). De-
tection and addressing the barriers by using for example motivational interviewing (MI) are 
of great importance. MI is demonstrated to improve PA leading to energy expenditure in-
crease between 26-37 % in two studies compared to control (137, 138). Barriers in persons 
with HF also include lack of time and is related to suffering from minor injuries or feeling 
physically tired. The psychological motives seem to be the utmost reason to perform PA. The 
wish of being healthier and live longer but also to slow the aging process and feel younger is 
experienced by 50%, rating physical and social motivations as least important (139). The 
challenge with PA and evaluating new PA in HF is to understand the concomitant lack of ad-
herence (140). Klompstra et al. found in their recent study on exergaming in persons with HF 
that exercise self-efficacy had a role in explaining the relationship between motivation and 
PA and may therefore affect adherence to recommended PA (139). Self-efficacy can be de-
veloped through realistic goal-setting, supervised exercise training and support (141). Per-
forming PA as suggested in HF guidelines remains low for both male and female (132) but 
females seem to have a higher motivation than men (139). Comorbidity by coronary diseases 
is to be considered as present in more than 60% of person with HFpEF and HFrEF and care-
ful evaluation during exercise is needed concerning exercise limitation due to impaired car-
diac reserve (142).  
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5.1.7 To influence physical activity 
Education has been identified as an opportunity to improve a person’s ability to perform self-
care (143, 144). Evidence based recommendations are stated in European guidelines, what a 
person affected by HF needs to know about their sickness for optimal self-care (2, 4, 37). The 
persons are urged to register the weight daily and respond to weight gain of > 2-3 kg, which 
should lead to an increase of diuretics for 3-4 days, but also the evaluation of the expected 
weight loss and decrease of the symptom burden (41). The self-care councils that are disease-
specific and gives non-pharmacological treatment also include the importance of smoking 
cessation as well as reduction of alcohol consumption, sexual counseling and finally a low-fat 
diet (37). The level of education found in Klompstra et al study was significantly associated 
with the levels of PA. Persons performed high PA had higher exercise self-efficacy and 
higher exercise motivation compared to those with a low PA level. No differences were 
found between those with a high PA level towards a low regarding gender, NYHA classifica-
tion or comorbidity (139). Problems in the HF self-care process concerning knowledge has 
been analyzed in relation to neural alterations associated with HF. As a neural process, deci-
sion making has been traced to regions of the prefrontal cortex, the same areas that are af-
fected by ischemia, infarction, and hypoxemia in HF. This in turn leads to deficits in memory 
and attention but also may impair the perception and interpretation of early symptoms and 
signs of deterioration in HF (143). Reflection or contemplation is linked to knowledge acqui-
sition (60). 
5.1.8 Support from society, health-care and caregivers 
Education, counseling and learning skills always need additional development and improve-
ment as life and circumstances constantly changes. Together with caregivers that take an ac-
tive part in home-based interventions, support can improve outcomes by strengthening the 
ability to self-care (145). For the caregiver there is also a lot of related factors found that af-
fect the caregiver burden over time. Liljeroos et.al found that when the person with HF was 
younger, had less comorbidity, higher level of perceived control, physical health and less 
symptoms of depression resulted in a better health in the caregiving partner (49). The family 
caregivers expressed a need for patience, as well as a compassionate way to cope with frus-
tration. They expressed that personal qualities such as compassion, thoughtfulness and under-
standing were considered essential requirements in the caregiving role (146). HF often requir-
ing in-hospital care but also at home-based care in different periods of the sickness. Educa-
tional interventions targeting the socio-cultural influences of the person with HF together 
with their caregivers through a structured and well-designed program may improve outcomes 
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(147). Important motivators for PA in adults include advices from health care providers. 
There is also a concern from persons about the safety, lack of facilities nearby, weather con-
cerns or shortage of sidewalks or places to sit and rest. It is also a concern of responsibilities 
within the family or caregivers, not to forget those, with a lack of social support concerning 
PA (110, 148). In HF there are no differences found in potential barriers between men and 
women concerning PA (139). Conducting in-depth interviews with 35 adults on average of 
67 years of age, they described existing barriers and facilitators to neighborhood-based activ-
ity with mobility disabilities. Preparing the neighborhood environments for an aging popula-
tion that uses assistive devices is important in the future (149). However, persons also de-
scribed that performance of PA needs to be purposeful and fun (148). A review made of 31 
studies also supported the fact that there is a relationship between the physical environment 
and PA among older adults (150). 
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6 YOGA TO IMPROVE HEALTH RELATED QUALITY OF 
LIFE  
Yoga therapy is difficult to define, partly because the discipline can be approached in many 
ways, both in respect to traditions but also by compositions and intensity of postures and dif-
ferent meditations. A reasonable and pragmatic understandable statement in defining yoga is 
set by the International Association of Yoga Therapists (IAYT) as ”yoga therapy is the pro-
cess of empowering individuals to progress toward improved health and well-being through 
the application of the teachings and practices of yoga” (151). Asia is origin of yoga from an-
cient times, many thousands of years ago. Yoga originated as a philosophical or spiritual dis-
cipline to deliver practitioners from suffering and is defined in Sanskrit as” to join”(152). The 
autonomic nervous system regulates the parasympathetic and sympathetic systems and 
inﬂuences functions such as digestion, heart rate, and respiratory rate as a compulsory stabi-
lizing response to stress and other environmental challenges (153). Yoga can be described as 
a body and mind therapeutic intervention that includes a lifestyle aspect. Yoga has been used 
for persons with depressive disorders and elevated levels of depression (154, 155) and is sug-
gested as a treatment option for persons with HF. Yoga is especially characterized to achieve 
mental, emotional and physical balance of sentient beings (156-158). Treatment of yoga in-
cludes breathing exercise (pranayama) (159), postures (asanas) (160) and meditation (dyana) 
(161, 162). Meditative music is usually played during parts of the sessions of yoga (163). 
6.1.1 Yoga breathing (pranayama) 
The yogic breathing technique of pranayama involves many different techniques but the most 
common is the slow deep breathing inspired with the predominant use of the abdominal mus-
culature and the diaphragm. The breath is held momentarily in full inspiration within the lim-
its of comfort and allowed slow and spontaneous exhalation (164). Several factors contribute 
to the reduced exercise tolerance that has been identified in persons with HF, including altera-
tions in central hemodynamics, skeletal muscle oxygen utilization and respiratory muscle 
dysfunction (165). Respiratory, or inspiratory muscle training (IMT) has shown potential 
beneficial effects in persons with HF such as improved peak VO2 (166). Smart et.al con-
ducted a review on eleven studies containing data on 287 persons with HF performing IMT 
compared to control. Respiratory muscle training improved cardio-respiratory fitness and 
peakVO2 and showed better results in the functional 6MWT together with an increase in 
HRQoL (167). Another study indicate that IMT improves cardio-respiratory fitness and 
HRQoL to a similar magnitude as conventional exercise training (121). Ekman and Kjell-
ström investigated if lowering breathing rate with the help of a respiratory modulation (RM) 
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twice daily or listening to music for four weeks could improve breathlessness and NYHA 
class in persons with HF. RM resulted in having a potential to relieve symptoms of HF by 
changing the breathing patterns together with an improved NYHA class (168). Baroreflex 
sensitivity is a measure of the heart’s capacity to efficiently alter and regulate heart rate and 
blood pressure in accordance with the requirements of a given situation. A high degree of 
baroreflex sensitivity is thus a good marker of cardiac health (169). With a multitude of dif-
ferent breathing techniques in yoga, slow breathing consisting of equal inspiration and expira-
tion seemed to be the best technique for improving baroreflex sensitivity (159, 170, 171). 
Contrary, Mason et.al suggested in their study that practitioners of yoga can engage in a ratio 
that is personally comfortable and achieve the same benefit of the baroreflex sensitivity (172).  
6.1.2 Yoga postures (asanas) 
Yoga essentially involves the adoption and maintenance of certain simple to complex body 
asanas. Yoga movements are usually a combination of physical moves aimed for balance of 
energy disturbances in body and mind. The asanas can be performed sitting, lying or standing 
and performed in different combination postures. The asanas consists of a combination of for-
ward, backward and sideward bends, twists and balance poses individually modified accord-
ing to medical or orthopedic limitations if needed from the body. Jayasinghe (164) describe 
that the ancient practice of yoga has notes that contains 840 000 asanas. Of these only some 
are recommended to be useful for regular practice. The common advice for each asana is to 
be maintained for a period of 5–20 breaths. 
6.1.3 Yoga meditation (dyana)  
Meditation can be described as a combination of complex emotional and attentional regula-
tory strategies developed for various reasons, including the cultivation of well-being and 
emotional balance (173). Two different parts of dyana techniques are usually combined, fo-
cused attention meditation with or without mantras "instruments of thoughts" and open moni-
toring meditation. The goal of these meditations is to reach a state in which no explicit focus 
on a specific object in retained by remaining attentive moment-by-moment to anything that 
occurs in the mind (174, 175). The potential regulatory functions of these practices on atten-
tion and emotion processes can have a long-term impact on the brain and behavior (173). 
Meditation is thinking of nothing or rather not thinking of something and is a challenge to 
balance. The concentration or rather relaxation of mind is dependent on the ability to resist 
distractions from the outer and inner world and control of their impulses and emotions. Medi-
tation may involve an internal effort of self-regulating the mind (173, 176, 177). A review of 
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nine studies investigating the effect of meditation, seven demonstrated improvement in symp-
tom relief. Relaxation, meditation, guided imagery, or a combination of these strategies re-
sulted in less dyspnea and better sleep compared with attention control or usual care. Medita-
tion also reduced pain, dyspnea, fatigue, and sleep disturbance within the treatment group 
(162). There are numerous scientiﬁc research in assessing potential health beneﬁts of various 
types of meditations as in e.g. neuroscience, meditation induces neuroplasticity in the brain 
(178) which allows the neurons (nerve cells) in the brain to compensate for injury and disease 
and to adjust their activities in response to new situations or to changes in their environment 
(174). It is the brain's ability to reorganize itself by forming new neural connections through-
out life. Recently, meditation has been explored with quantitative parameters by Bhaduri et.al 
using instantaneous heart rate in beats/minute. The cardiac dynamics during meditation was 
measured during performance of Kundalini yoga or Chi meditation. The cardiac dynamics 
changed in complexity supporting that these techniques could affect physiological responses 
during meditation (179). A novel study in the area of HF is the evaluation of mindfulness-
based interventions with promising results significantly reducing the self-reported impact of 
fatigue, symptoms of unsteadiness/dizziness and breathlessness/tiredness related to NYHA 
class (180).  
6.1.4 Yoga music 
Another novel area of science is the content of yoga music and its influence in the brain. 
Maity et.al present data regarding neural activation of the alpha and theta brain wave trough 
EEG rhythms while listening to simple acoustical stimuli. The findings showed spectral 
width showing that the complexity of alpha and theta rhythms increased in all the seven 
frontal locations in the brain studied, as an effect of musical stimuli. This led to a quantifica-
tion of emotions using multifractal spectral width as a parameter to be used in cognitive mu-
sic therapy (181).  
6.1.5 Effects of yoga  
Yoga has been reported as an effective modality in improving various physical and psycho-
logical aspects of elderly populations, and in the review by Patel et.al of 18 studies with 649 
older adults they suggested that yoga may be superior to conventional PA interventions in el-
derly persons concerning self-rated health status, aerobic fitness, and strength but the evi-
dence was mixed for yoga's effect on depression and sleep (182). Mooventhan & Nivethitha 
concluded in their recent review of elderly individuals that regular practice of yoga can be 
considered as an effective intervention of improving physically, through reduces heart rate, 
blood pressure, blood glucose, oxidative damage, reduced fatigue and weakness. There was 
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also a decrease in the fear of fall, and improvement of heart rate variability, baroreflex sensi-
tivity, insulin sensitivity, physical functions, mobility, flexibility, and urinary incontinence. 
Further, there were mental effects through reduced anxiety and depression. Emotionally eval-
uated through reduction of anger, stress, tension and improved self-efficacy. The social bene-
fits showed improved life satisfaction and vitality together with offering a better quality of 
sleep and HRQoL (183). Yoga has also demonstrated a potential modality in cardiovascular 
rehabilitation with positive effect in cardiovascular diseases like new highlights on hyperten-
sion and atrial fibrillation with promising result showing lower blood pressure, heart rate and 
improved HRQoL (184, 185).  
6.1.6 Yoga and heart failure 
Despite all these positive results from studies of yoga in general, little is known about yoga 
for persons with HF. Yoga interventions in HF started 2008 with two small RCT studies in a 
young population with promising results on inflammatory markers and exercise capacity 
studied by Pullen et.al (186, 187). A small prospective study by Howie-Esquivel looked at 12 
persons with HF in NYHA I-II without control group shortly after discharge from hospital. 
They demonstrated yoga as safe and feasible with improvement in physical function such as 
strength, balance and endurance but also symptom stability of the dimension of HRQoL 
(156). Gomes-Neto et al.(188) described in a meta-analysis the effects of yoga among per-
sons with HF. Two studies met the selection criteria with a total of 30 yoga and 29 controls. 
They stated a significant improvement in peak VO2 with 22% in favor to yoga and signifi-
cant improvement in HRQoL with an increase of 24.1%. Even though small studies have 
shown promising results Cramer et.al (189) gave weak recommendations including two 
RCT´s in their review of yoga for persons with coronary heart disease, HF and cardiac ar-
rhythmias. Findings showed that the mortality and morbidity data was poor, and the studies 
demonstrated low evidence in exercise capacity and HRQoL. A study by Krishna et al. in-
cluded 130 persons with HF performing yoga in comparison with CG, showed significant im-
provements in left ventricular ejection fraction in favor for yoga after 12 weeks. NT-pro BNP 
was reduced with 64% in the yoga and 11% in CG together with a significant decrease in 
heart rate, blood pressure and rate pressure product (RPP) in yoga compared to CG (157, 
158). Shortly after Kelley et al. carried out a systematic review of previous meta-analyses ex-
amining the effects of meditative movement therapies in adults and suggested that meditative 
movement therapies like yoga, tai chi and qigong may improve HRQOL in adults with se-
lected conditions like HF (190). Metin et.al (191) summarize in their review that mind and 
body therapies is a safe and cost-effective way to manage HF symptoms and improve 
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HRQOL. A novelty in yoga is Tele-yoga for persons with HF. This has been evaluated in a 
small pilot-study and was found acceptable and appropriate (192). However, there has been 
recent evaluations demonstrating small-to-moderate positive effects on HF outcomes as psy-
chological status, symptom relief, and HRQoL (191, 193). Still, there is a need of gathering 
information about type of yoga mode, frequency, duration and intensity of the activity in 
larger multicenter studies (103). Still up to date there is a lack of evidence for guideline rec-
ommendations for yoga performance in clinical practice. 
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7 RATIONALE  
Between 2000 and 2015 a substantial gain in life expectancy has been shown worldwide (28). 
Simultaneously there are gaps in the evidence on what can be done to improve the self-care 
process and HRQoL in persons with HF (16). HF is a very common condition in older per-
sons posing a high burden on the individual affected, due to symptoms of reduced physical 
capacity, poor HRQoL and decreased mental well-being together with a financial burden on 
the society, partly due to frequent hospitalization (7, 19, 194). HF is the most common reason 
to seek care at the emergency department (4). The self-care process is important in persons 
with HF in order to be able to manage their disease in the best way and reach a stage of stabil-
ity and better HRQoL (37). Motivation and self-efficacy is of great importance in order to 
gather information and learn about the disease (195). Together with detecting, monitoring and 
resolving important factors that can affect the health-status (61). Knowledge of the signifi-
cance of self-care such as daily weighing, adherence to treatment, detecting early signs of de-
terioration such as fluid retention, possibilities for medicine adjustment and the positive ef-
fects of PA is important for persons with HF (37). The rapid increased use of technology 
brings an opportunity to support self-care using mHealth (83). Today easy accessible tech-
nical tools of mHealth could be of importance for older persons with HF (196). To increase 
self-care, knowledge and adherence with a possibility to affect hospitalization in HF. In HF 
PA is a part of self-care and is well established with recommendation in guidelines (4, 114). 
PA is highlighted as a key component to improve HRQoL (101). Ability to perform increased 
activity trough yoga, as a combination of balance in body and mind, may have effects on 
HRQoL. To develop and introduce new innovations concerning mHealth and different moods 
to enhance PA and mental balance in self-care is of great importance for persons with HF. 
When optimizing self-care in HF, it is also of great value to evaluate and understand experi-
ences of the persons using new technical tools. 
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8 AIMS 
The overall aim of this thesis was to describe experiences and evaluate the effects of inno-
vative self-care approaches such as the mHealth system and yoga among persons with heart 
failure.  
8.1 SPECIFIC AIMS 
Aim study I The primary endpoint was to evaluate whether a new mHealth system consist-
ing of a tablet computer connected to a patient scale influenced self-care behavior. Second-
ary endpoints were health-related quality of life, adherence to mHealth, disease specific 
knowledge and hospital days due to heart failure after three months. 
Aim study II To determine the results after six months follow up, using the mHealth sys-
tem concerning self-care behavior, health-related quality of life, disease-specific knowledge 
and hospital days due to heart failure, together with an analysis on how the mHealth system 
was used. 
Aim study III To test the mHealth system in combination with a theoretical base “the situ-
ation specific theory of heart failure self-care” but also to explore the experiences in per-
sons with HF using a tablet computer and develop an understanding of the acceptability, 
perceived usefulness and potential areas of support. 
Aim study IV The primary endpoint was to determine whether yoga and hydrotherapy 
training had an equal effect on disease specific and generic HRQoL. Secondary endpoints 
were to compare the effects of exercise capacity, clinical outcomes, anxiety and depression 
between and within the two groups. 
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9 METHODS 
9.1 DESIGN  
This thesis is based on four studies combining both quantitative and qualitative methods for 
data collection and analysis. To immerse knowledge and evaluate the effects of a new 
mHealth system on HF self-care, HRQoL, disease specific knowledge and hospitalization 
days, quantitative data was collected. In study I and II a multicenter randomized controlled 
design was used with a follow-up assessment after three and six months. To get a better un-
derstanding of the experiences of the persons who used the mHealth system, a qualitative ap-
proach was applied by interviews in study III. Study IV was a single center randomized con-
trolled pilot study with a follow-up assessment after three months comparing two physical in-
terventions, yoga and hydrotherapy by HRQoL, exercise capacity, anxiety/depression and 
leg-endurance.   
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Table 2. Overview of design, methods and analyses in study I-IV.  
  Study I Study II Study III Study IV 
Approach Quantitative Quantitative Qualitative  Quantitative 
Design Randomized con-
trolled multicentered 
Randomized controlled 
multicentered 
Descriptive Randomized controlled 
single centered 
Participants 82 persons with HF 82 persons with HF 17 persons with 
HF 
40 persons with HF 
Data 
collection 
Questionnaires 
 
Questionnaires Semi structured 
interviews 
Questionnaires, physical 
tests 
Data 
analysis 
Descriptive statistics 
χ2test, Student´s t-test 
Mann-Whitney U test 
Wilcoxon, 
Poisson-log- 
linear regression, 
 Descriptive statistics 
χ2test, Student´s t-test 
Mann-Whitney U test 
Wilcoxon, 
Poisson-log- 
linear regression, 
Descriptive sta-
tistics 
Deductive 
qualitative con-
tent analysis 
Descriptive statistics 
χ2test, Student’s t-test 
Mann-Whitney U test 
Paired t-test 
Data 
collected 
Baseline and after 
three months. 22 
Febr-18 June 2013 
Baseline and after six 
months. 18 June-10 
Nov 2013 
During the in-
tervention after 
three months. 
April- 
June2013 
Baseline and after three 
months. Feb. 2011-Jan 
2012 
HF=Heart failure 
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9.1.1 Study participants 
The total number of participants included in all the studies was 211 with 139 unique individu-
als. Study I-III are based on data from the same individuals, 82 persons with HF that signed 
the informed consents in three inner city hospitals in Stockholm area, Sweden, Karolinska 
University hospital, SÖS hospital and Danderyds hospital. In study I-IV the inclusion criteria 
were HF based on the diagnosis criteria, according to current guidelines of the European So-
ciety of Cardiology (144). Forty percent of the persons included in study I and II had a newly 
diagnosed HF. The persons should not have been referred to a nurse-led HF-clinic within the 
last year and were referred straight to primary care. All persons were prescribed with diuret-
ics. 
 
Figure 1. Flowchart study I-III 
 Flow Diagram study I-III 
Assessed for eligibility (n=156) 
Excluded (n=74) 
Not meeting inclusion criteria (n=70) 
Other reasons (n=4) 
Analyzed (n=32) 
 
Death (n=3) 
Withdrawal of consent (n=2) 
Non-completed questionnaires (n=5) 
Allocated to intervention mHealth (n=42) 
Did not receive allocated intervention due 
to withdrawal of consent (n=10) 
 
 
 
Death (n=5) 
Withdrawal of consent (n=3) 
Non-completed questionnaires (n=9) 
 
 
 
Allocated to Control (n=40) 
 
Analyzed hospitalization (n=40) 
Analyzed questionnaires (n=23) 
 
 
 
Allocation 
Analysis study I 
Follow-Up 
Randomized (n=82) study I 
Enrollment 
Assessed for eligibility qualitative interview (n=32) 
 ((32(n=32) 
Analysis study II 
Analyzed hospitalization (n=32) 
Analyzed questionnaires (n=22)  
 
 
Analyzed (n=40) 
 
 
Analyzed interview (n=17) Analysis study III 
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Persons randomized in study I and II were referred to either intervention with the mHealth 
system (n=42) or control (n=40) with usual care, experiencing NYHA class II-IV. Exclusion 
criteria in study I and II were other serious conditions with a life expectancy less than six 
month, diagnosed dementia or cognitive impairment of such severity that it would make the 
person unable to understand provided instructions. Data regarding hospitalization in study I 
and II were analyzed per protocol based on data from 72 persons who completed the study. 
An approach of intension to treat analysis was made for the remaining data. Study III was 
performed as semi-structured interviews from those persons with HF who had used the 
mHealth system in study I. All (n=32) persons participated in the intervention group with 
mHealth were asked to participate in an interview and 17 persons approved. The interviews 
were audio recorded and transcribed verbatim, using a deductive theory-driven approach us-
ing “the situation specific theory of heart failure self-care”(43), (Figure 1). 
 
 Flow Diagram study IV 
Assessed for eligibility (n=102) 
Excluded  (n=62) 
   Not meeting inclusion criteria (n=60) 
   Other reasons as skin wounds allergic 
to chlorine (n=2) 
Analyzed included (n=12) 
 
Discontinued intervention (n=8) 
Transportation 
Muscular skeleton injuries 
Memory problems 
Worsening condition due to HF or other 
sickness 
Allocated to intervention Hydrotherapy (n=20) 
 
 
Discontinued intervention (n=2) 
Worsening condition due to HF  
Muscular skeleton injuries 
 
 
 
Allocated to intervention Yoga (n=20) 
 
Analyzed included (n=18) 
 
Allocation 
Analysis study IV 
Follow-Up 
Randomized (n=40) 
Enrollment 
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Figure 2. Flowchart study IV. 
In study IV the persons were randomized to exercise two times per week by either hydrother-
apy (n=40) or yoga (n=40). The inclusion criteria were HF in NYHA-class I-III and all had 
visited the out-patient HF clinic for optimizing of the medical treatment prior to enrolment. 
Persons with diagnosed dementia, other serious conditions with a life expectancy of less than 
six months or scheduled for heart transplantation were excluded. Furthermore, those unable 
to understand oral instructions were excluded. An upper age of 80 years was chosen in study 
IV. Persons addicted to alcohol or drugs, incontinent, having wounds or being allergic to 
chlorine were also excluded, (Figure 2). 
9.1.2 Sample size 
Weighing in study I and II was a fundamental part of the intervention with the mHealth sys-
tem. A choice of the frequency of weighing found in the literature at the current time looking 
for the effect size of a similar intervention (197). An estimated adherence of 30% in CG and 
80% in IG resulted in 30+30 persons required to reject the null hypothesis with 80% power 
and a type I error probability of 5%. Considering the potential loss of persons, there was a tar-
get enrollment by 40 persons in the CG and 40 persons in the IG. The power calculation was 
performed by “Know It Decision” by a consulting agency on Dec 2012 (145). Study IV was a 
pilot study and therefore was no sample size estimated. 
9.2 PROCEDURES AND INTERVENTIONS 
9.2.1 The mHealth system  
Optilogg® can be described briefly as a compliance catalyst m-Health system developed in 
cooperation with hospital staff and evaluated in study I-III. It consisted of a tablet computer 
locked to a custom software prepared in advance and wirelessly connected to a weight scale 
installed in the person’s home. In stepping on the weight scale every morning, the weight was 
transferred to the tablet. Based on the weigh a built-in intelligence could detect a deterioration 
in the HF status and titrate the dose of diuretics. The tablet gave self-care advices and flexible 
doses of diuretic in case of deterioration with a weight increase > 2 kg in 3 days. The tablet 
was divided into four different selectable areas. The first was an automatic view that started 
every day when the person stepped on the scale with the weight in kilos, together with the 
recommended dosage of diuretics and a short tip on lifestyle recommendation HF self-care 
maintenance (37, 198). The second was a selectable view of content information of the HF 
disease (144) and lifestyle self-care recommendations according to current guidelines (37, 
199) for example like physical activity, smoking cessation, healthy salt-restricted food, fluid 
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restriction and immunization. The third area of choose was a view containing a graphical im-
age of trends showing variations in weight, use of diuretics and well-being over time with a 
Visual Analogue Scale (VAS) of HRQoL, including zoom and scroll functions. The last op-
tional area, contained contact details to responsible nurses and doctors at the outpatient HF 
clinic and to persons responsible for technical support. Every fifth day the persons estimated 
their HRQoL on the VAS scale that was stored in the third section. The m-Health system 
gave possibility to search for information in the tablet like adaptive education with a visual 
feedback trend at any time concerning self-care maintenance as performance of weight re-
sults, self-care management as diuretic medicine consumptions and generic HRQoL by the 
VAS. When the m-Health system detected HF deterioration instructions were given to up-ti-
trate the diuretics. If no change where noted after three days, instructions were given to con-
tact the healthcare provider. To assist in case of technical problems all had access to technical 
support. No data was sent to the hospital, which was an integral part of the mHealth system 
design. 
9.2.2 Hydro-therapy  
The persons randomized to hydrotherapy in study IV were on optimal medical treatment and 
had received self-care advices according to current guidelines by an out-patient HF clinic at 
the hospital (37, 144). A 45-minute hydrotherapy session was conducted twice a week in a 
heated therapy pool at the hospital. The water temperature was 31-32 degrees Celsius. The 
persons standing could reach the bottom of the pool. Each session consisted of endurance 
training in water in a standing, sitting or lying position. Training a single muscle group at a 
time, the exercises involved the arms, shoulders, back, stomach, seat and leg muscles. The 
exercise regime was designed to include muscles utilized in daily living such as walking, 
dressing and household activities. The focus was to exercise one muscle group at a time with 
the water as a resistance. The hydrotherapy followed a low to medium exercise level, with the 
central exercise level of 11-13 Borg RPE-20 scale and with 2x15 repetitions/muscle group 
(124, 125, 127). The hydrotherapy sessions were conducted by a certified physical therapist. 
The persons training hydrotherapy were asked to complement with a daily exercise program 
consisting of easy movements using the persons own weight together with a daily walk. 
9.2.3 Yoga 
The yoga performed in study IV springs originally from Kundalini yoga and is named 
Mediyoga® (200). The postures used in Mediyoga® are generally slower and more gently 
than in traditional yoga of Kundalini (see Appendix A). The yoga postures consisted of a 
combination of forward, backward and sideward bends, twists and balance poses individually 
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modified according to medical or orthopedic limitations if needed. The persons had received 
optimal medical treatment and self-care advices according to current guidelines through an 
out-patient HF clinic at the hospital (37, 144). In addition to the usual HF treatment, the per-
sons randomized to yoga performance, received a 60-minute yoga class twice a week. The 
yoga postures were performed standing, seated on chairs or yoga mats or lying down. Each 
person performed a total of 20-24 sessions over a tree months period. Every second week the 
sessions and meditations alternated between two different sets of combinations of yoga exer-
cises specially design to enhance the heart. A session included 10 minutes deep breathing ex-
ercises, 40 minutes of yoga postures and finally 10 minutes of relaxation together with medi-
tation. At the end of each session, participants had the opportunity to discuss their experi-
ences or issues. At the first visit everybody received a CD and a hand-out with yoga postures 
together with written instructions. The yoga sessions were performed at the hospital and con-
ducted by a certified yoga instructor. The persons were encouraged to practice yoga at home 
with a goal of one session a day. 
9.2.4 Control conditions 
In study I, II the persons randomized to control group received the same basic HF infor-
mation sheets as those randomized to intervention. The information sheet consisted of advices 
regarding HF self-care according to current guidelines with suggested action of increased 
dose of diuretics in case of weight gain (37, 198) and with a priority number to call in case of 
need. 
9.3 DATA COLLECTION AND MEASUREMENTS 
Background variables and participants characteristics such as age, gender, marital status, 
comorbidity, new onset of HF, NYHA classification and medication was collected through 
medical files and interviews. Study I- III were multicentered studies with three hospitals in 
Stockholm, Sweden. Study IV was a single centered study. Data in studies I, II and IV were 
systematically collected using questionnaires. The questionnaires were completed at inclusion 
and at three months follow up in hospital I and IV. In study II six months follow-up was 
made by sending the questionnaires in a stamped envelope in return to the hospital. In study I 
and IV blood samples were collected at the hospital or at a local laboratory. The capacity tests 
6MWT and STST test in study IV were performed at the hospital mostly with help from the 
local physiotherapist. In study II information about death and cause of death during the fol-
low-up were collected from medical records. In study III data were collected through semi 
structured interviews using an interview guide at the hospital or at the persons home (Figure 
3). 
  37 
9.3.1 Hospitalization 
The number of hospital days due to HF were collected at baseline and after 90 and 180 days 
in study I and II. We made a compilation of the HF-related hospital days during the same pe-
riod using information collected from the medical records. 
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9.3.2 Instruments 
Table 3. Variables and instruments used in study I, II and IV. 
Study Variables tested Instruments * ** *** 
IV Exercise capacity 6MWT – Six-minute walk test    
I,II,IV HRQoL KCCQ - The Kansas City Cardiomyopathy 
Questionnaire 
☒  ☒ 
I,II HRQoL  SF-36-Swedish version of the Health Survey  ☒ ☒ 
IV HRQoL EQ-5D - EuroQol-5D  ☒ ☒ 
I,II Heart failure Self-care EHFScB9 scale -The European Heart Failure 
Self-care Behavior Scale 
☒  ☒ 
I,II HF knowledge DHFKS - Dutch Heart Failure Knowledge Scale ☒  ☒ 
IV Anxiety and Depression HADS - Hospital Anxiety and Depression Scale  ☒  ☒ 
IV Depression  PHQ9 - The Patient Health Questionnaire de-
pression module 
☒  ☒ 
IV Leg endurance test  STS test - Functional in the lower limb muscle 
measured by the sit-to-stand test 
   
I,II Readmission hospital 
days  
Medical records    
* Disease specific instruments, ** Generic instruments, ***Tested in the Swedish population 
Six-minute walk test  
The 6MWT reproduces the activity of daily life and this is particularly relevant in elderly per-
sons who usually develop symptoms below their theoretical maximal exercise capacity. The 
6MWT is a standardized, reproducible, low-tech test of exercise capacity that measures the 
distance a person can walk on a flat, hard surface in six minutes. It evaluates the global and 
integrated responses of all the systems involved during exercise. Evaluation includes the pul-
monary, cardiovascular, systemic and peripheral circulation. Age, height, weight and gender, 
independently affect 6MWT (114, 201-204). The distance of relevance in HF is estimated to 
be between 30-36 m of change (205, 206). Borg´s Rating Perceived Physical Effort scale 
(207) was measured before and after 6MWT together with blood pressure, pulse rate and pe-
ripheral oxygen saturation test using an equipment from Nellore Oxi Max N-65P. The 
6MWT was used in study IV at baseline and after three months (Table 3).  
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Sit-to stand test  
The lower limb muscle function is measured by a sit-to-stand test. The test required the per-
son to stand up from and sit down on a slightly padded 43 cm high armless chair as quickly 
as possible for 30s. Persons were instructed to fold their arms across their chest and stand-up 
completely and make firm contact when sitting. On the command of “go” the timing started 
and ceased when the person sat after 30 s and the amount of performed movements where 
counted and used in the subsequent analysis. Persons could practice two repetitions. The test 
has been performed in older populations but the validation in the HF population is discussed 
(208-211). The STS test was used in study IV at baseline and after three months (Table 3). 
The Kansas City Cardiomyopathy Questionnaire 
KCCQ is a disease-specific instrument measuring HRQoL with 23-items, that quantifies six 
domains and two summary scores of a person’s health status. The six domains are physical 
limitations, total symptom score, symptom change, self-efficacy, social interference and qual-
ity of life. The two summary scores are clinical summary scores and overall summary scores. 
The items in KCCQ have five to seven response alternatives. All scale scores are transformed 
to 0-100 scale, with a higher score indicating better HRQoL. The instrument has been tested 
and validated in a Swedish HF population (36, 212). The KCCQ instrument was used in 
study I and II at baseline and after three and six months and in study IV at baseline and after 
three months (Table 3). 
Swedish version of the Health Survey Short Form 36 
SF-36 is a frequently used instrument to assess generic HRQoL both physically and mentally. 
The instrument includes eight multi-item scales plus a single-item scale, to compare the per-
sons current health with the health one year ago. The eight domains are physical functioning, 
physical role, bodily pain, general health vitality, social functioning, role of emotional health 
and role of mental health. SF-36 also consists of two summary scores; mental component 
score (MCS) and physical component score (PCS). The scores are transformed into a scale 
were higher scores indicate better HRQoL ranging from 0-100 with 0 as worst possible health 
and 100 as best possible health. The SF-36 has good reliability and validity and is tested in 
the Swedish population (32, 213, 214). The SF-36 instrument was used in study I and II at 
baseline and after three and six months (Table 3). 
EuroQol-5D 
EQ5D is a generic instrument and measures health related quality of life. The EQ-5D consists 
of two parts. The first part includes 5 dimensions of health state classification (mobility, self-
care, daily activities, pain/discomfort, anxiety/depression. The responses are classified in 3 
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levels of severity (1 = no problems, 2 = moderate problems and, 3 = severe problems). The 
answers in each of the scales are graded and given an index according to a weight trans-
formed to 1.0 representing full health and -0.59 representing the lowest possible health index. 
The index score (EQ-index) can calculate 243 theoretical possible health statuses. The second 
part of EQ-5D is the Visual Analogue Scale (EQ-VAS) that evaluates self-rated health on a 
vertical, visual analogue scale, where the endpoints are labeled 0 (worst imaginable health 
state) to100 (best imaginable health state). EQ5D has good feasibility, validity and reliability 
(33, 215-217). This instrument was used in study IV at baseline and after three months (Table 
3). 
The European Heart Failure Self-care Behavior Scale 
EHFScB-9 is an instrument that measures self-care behavior that persons with HF perform to 
maintain life, wellbeing and healthy functioning. The EHFScB-9 scale consists of nine-items 
with alternative answers on a five-point Likert scale from 1 (I strongly agree) to 5 (I strongly 
disagree). The total score ranges between 9-45 and lower scores indicates better self-care be-
havior. The reliability of this score is tested with Cronbach’s alpha method with consistency 
usually between 0.68 and 0.87 in different countries. The EHFScB-9 scale has been tested 
and found to be user friendly and have good reliability and validity (197, 218, 219). This in-
strument was used in study I and II at baseline and after three and six months (Table 3). 
Dutch Heart Failure Knowledge Scale  
DHFKS has 15 questions concerning knowledge about HF. Each question has 3 fixed alterna-
tive answers. The correct answer gives 1 point (range 0-15). The instrument has been tested 
and found to be user friendly and have good reliability and validity (220). The DHFKS was 
used in study I and II (Table 3). 
The Hospital Anxiety and Depression Scale 
HADS is a valid and reliable instrument used in HF. The scale consists of 14 statements that 
are answered on a four-point scale. Seven statements designed to measure anxiety (HADS-A 
range 0-21) and seven measures depression (HADS-D range 0-21). This test can validate the 
existence of symptoms together with their severity. (221, 222). The HADS was used in study 
IV at baseline and after three months (Table 3). 
The Patient Health Questionnaire depression module 
PHQ-9 is a brief self-rating scale for screening major depressive disorder and measuring the 
current level of symptoms of depression. Each of the nine-items are scored from 0 to 3, with 
0 meaning no symptoms at all and 3 symptoms nearly every day. The sum of the scores can 
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be used as a measure of current symptom level to assess depression depth and follow a pro-
gression over time. PHQ-9 scores of 5, 10, 15, and 20 represented mild, moderate, moder-
ately severe, and severe depression, respectively. The instrument is a reliable and valid meas-
ure of depression severity (223). PHQ9 was used in study IV at baseline and after three 
months (Table 3).  
The main research question of interest in study III was to develop an understanding of the ex-
periences from persons with HF using the mHealth system, a tablet computer wirelessly con-
nected to a weight scale. The first question in the interview was concerning the main aspects 
of phenomena that were investigated: “Can you tell me about your own experiences of using 
the mHealth system?” To get a deeper understanding of the experiences, follow up questions 
was used like: Direct questioning of what just had been said or mere nod, or “mm” or a 
pause. Mostly probing questions was used like: “Can you tell me in what way you found.?” 
or “Please tell me how you experienced...?” “Can you please elucidate me more about...?” 
Structured questions were used to indicate when an area had been exhausted, to move to the 
next topic. In the interview there was allowance of reflected silence with active listening. In-
terpreting questioning to clarify and rephrasing was used. With attention to the linguistic na-
ture of the interaction in the interview, there was a focus on the wording of the questioning, 
which was adapted to the subject matter and the purpose of the study (Figure 3). 
 
Figure 3. Interview topic guide with semi structured directed areas. 
 42 
9.4 DATA ANALYSIS 
9.4.1 Statistical analysis 
In study I, II and IV basic statistics were used consisting of descriptive statistics, correlations, 
t-test and various tables to organize and describe the study variables and populations. De-
pending on the examined variable different methods of parametric or non-parametric tests 
were chosen. As a measure of position, the data was tested for normality. The results were 
presented as mean, median or quartiles for numerical data. Categorical variables were pre-
sented as frequencies and percentages. In measuring the dispersion, the variance, standard de-
viation, interquartile range or range was used. The data was presented as grafts and/or tables 
as appropriate. Univariate statistics on differences of baseline variables were calculated by 
the Student t-test if normally distributed or if not by Mann-Whitney test. Descriptive statistics 
were expressed as means -+ standard deviation (SD) for continuous variables. For categorical 
variables medians with interquartile range (IQR) and/or frequencies and percentages was 
used. Differences in means, medians or ratio were tested by 1-way analysis of variance, Krus-
kal-Wallis test or multifrequency cross-tables. If both variables tested were numeric the Per-
sons parametric or Spearman’s non-parametric correlation was performed depending on nor-
mality and variance. If one variable was numeric and the other variable categorical with nor-
mality and equal variance a t-test for independent samples was used to discover differences 
between the groups. If data was not normally distributed or without equal variance, differ-
ences were tested by Mann-Whitney test. 
In study I and II correlation between two independent categorical variables were tested with 
chi-square statistics. In post-hoc analyses, Student t-test, Mann-Whitney U test or x-test were 
used as appropriate. In study II differences between the intervention and control were ana-
lyzed using a χ2test or a Student’s t-test for independent samples. Log-rank test  was used for 
time to death or heart failure hospitalization, for survey-based variables. To analyze the num-
ber of hospital days per person and six months a Poisson log-linear regression was per-
formed. Other outcome variables consisting of one categorical and one numerical the Mann-
Whitney for independent and for dependent samples the Wilcoxon test were used. 
In Study IV the descriptive statistics were expressed as means and standard deviations for nu-
meric variables. Categorical variables were presented as frequencies. Univariate statistics on 
differences of baseline variables were calculated by the χ2test, Mann-Whitney test or Stu-
dent’s t-test depending on numeric or categorical variables. Differences between the persons 
performing hydrotherapy and yoga were analyzed using a Student’s t-test for independent 
samples. Within group analysis were performed using paired t-test. 
Statistical calculations in study I, II were performed in R, version 3.0.1. and in study IV 
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PASW statistics version 18 (IBM Corporation 2010, IBM Corporation, Route 100 Somer, 
NY 10589). The level of statistical significance was p< 0.05 for study I, II and IV. 
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9.4.2 Qualitative analysis 
 
Figure 4. Coding framework of the predetermined categories, based on “the situation specific theory of heart 
failure self-care". 
A qualitative design was used in study III with semi structured interviews following an inter-
view guide, (Figure 3) and analyzed by inspiration of qualitative manifest content analysis 
(224). Using a deductive approach relating to “the situation specific theory of heart failure 
self-care” (43), (Figure 4). The deductive analysis process started with three main phases: 
preparation, organizing and reporting in a manifest content way. Meaning units were elected 
from the data followed by a coding according to a structured matrix consisted of the tree cate-
gories within the theory of self-care. The data summaries into codes and further into sub-cate-
gories which was the base for presentation (Table 4). 
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Table 4. Meaning units (MU), codes and sub-categories in study III. Unpublished data 
CATEGORY MU CODES SUB-CATEGORIES 
Maintenance MU=181 39 Weight Adherence MU=82 
  18 Routines   
  11 Diet   
  8 Fluid restriction   
  6 Physical activity   
  29 Health care  Support MU=67 
  24 Self -care advice   
  14 Medical treatment   
  32 Heath care Obstacles MU=32 
Symptom perception MU=67 36 Weight gain Physical symptoms MU=61 
  8 Fluid retention   
  6 Swollen legs   
  3 Coughing   
  3 Obesity   
  2 Physical impairment   
  4 Dyspnea   
  3 Non-well being Psychological sensations MU=6 
  2 Fatigue   
  1 Stress   
Management MU=63 11 Insight in HF treatment Developing and using skills MU=41 
  9 Evaluation of treatment   
  8 Decision making   
  5 Healthy lifestyle   
  5 Keeping fluid restriction   
  3 Keeping diet   
  14 Self-care medical treatment diuretics Independence MU=20 
  2 Not following fluid restriction   
  1 Not taking diuretics   
  1 Not following smoking restriction   
  2 Call health care professionals Cooperation MU=2 
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 ETHICAL CONSIDERATIONS  
The goal was to perform all studies per principles of autonomy, not harming, beneficence, 
with justice and respect for human rights described in the World medical association Declara-
tion of Helsinki (225). To do so there was primarily permission obtained from the Regional 
Ethical Review board in Stockholm for all studies, study I (DNR: 2012/2176-31/1) study II 
(DNR: 2012/2176-31/1) study III (DNR: 2013/1778-32) and study IV (DNR: 2010/1452-
31/4). All persons received verbal and written information about the studies before signing a 
written consent before entering the studies. A patient is always in an inferior position and de-
pendent on health care, especially when newly diagnosed and not in the best of health. To ask 
for participating in a study may augment the dependent position of the person. This could be 
avoided as in study I, II and III with the researcher not involved in the clinical care of the per-
sons participating. The numbers of questionnaires were carefully considered prior to the stud-
ies, the time and effort given by the persons participating, filling in all the data in question-
naires and discomfort of pain caused by blood samples and exhaustions due to physical tests 
were considered. Respect was paid to the persons privacy and serious condition. Participation 
in the interventions in study I, II and IV may have resulted in large commitments, as dedi-
cated time to perform the interventions and costs for traveling. In return the participants were 
examined and followed-up for their HF at the hospital free of charge. In study IV they could 
keep the received free yoga material after the intervention. The persons in study I and II could 
not keep the technical mHealth tool that they had used. All the persons participating in inter-
ventions with an instructor in hydrotherapy or yoga in study IV was free of charge. In cases 
where the persons were expected to send questionnaires to the research team, they were pro-
vided with pre-stamped envelopes. Study III that was an interview study to evaluate experi-
ences of the mHealth tool used for three months. The persons may have participated in the in-
terviews as obligations and as a sign of gratitude and may not have revealed negative experi-
ences.  
 
  47 
10 RESULTS 
A total of 82 persons accepted to participate in study I and II and completed the baseline 
measures, but the results are based on the results of 72 persons that completed the study. In 
study III 32 persons were asked to take part in an interview and 17 persons agreed. In study 
IV 40 persons accepted to participate and the results are based on the 30 persons that com-
pleted the three months follow-up. Demographic data shown in Table 5. 
Table 5. Demographic and clinical characteristics, comorbidity and medication for partici-
pants in study I-IV. 
Variable Study I Study II Study III Study IV 
  IG 
(n=32) 
CG 
(n=40) 
IG 
(n=32) 
CG 
(n=40) 
n=17 YG 
(n=18) 
HG  
(n=12) 
Gender % female  66 70 66 70 35 25 45 
Age, mean (SD±), y  75(8) 76(7) 75(8) 76(7) 75(8) 64.1(9.4) 65.7(8.5) 
Civil status, single %         23     
Drugs               
ACE-I %           90 90 
ACE-I/ARB % 69 78 69 78       
Betablockers % 97 88 97 88       
Diuretics %           75 95 
Furosemide equivalent % 100 100           
Loop diuretics dose/mg  65(65) 92(66)           
Statins %           35 50 
Warfarin %           35 45 
MRA % 38 30 31 30   25 35 
Co-morbidities               
Myocardial infarction % 22 23 22 23   35 40 
Ischemic heart disease %     9 18   20 20 
Atrial fibrillation % 47 73 47 73   40 40 
Diabetes mellitus % 34 45 34 45   15 15 
Stroke %           5 5 
Hypertension % 56 45 56 45   30 20 
COPD % 13 23 13 23   0 0 
Cancer %           1 1 
Hyperlipidemia % 6 8 6 8       
Renal failure % 9 8 9 8       
Syncope % 6 3 6 3       
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Newly diagnosed % 47 35 47 35 41     
Lab tests               
Creatinine (SD) 112(37) 107(98)       82.3 
(19.5) 
110.2 (47.2) 
Hemoglobin (SD)           136.5 
(17.4) 
134.0 (14.5) 
NT-ProBNP (SD)           1408 
(1419) 
1589 (1703) 
Devices               
Pacemaker %           10 10 
CRT %           10 20 
ICD %           15 35 
CRT-P/CRT-D/ICD % 16 20           
NYHA               
I %           25 35 
II % 38 18 38 18   40 30 
III % 62 82 63 83   35 35 
Continues variables are presented as mean (SD±) and categorical variables are presented as percentages. 
CRT:cardiac resynchronization therapy; ICD:implantable cardioverter defibrillator; NYHA:New York Heart As-
sociation Classification; COPD:Chronic obstructive pulmonary disease; MRA:Mineralocorticoid receptor antag-
onist; ACE-I:Angiotensin-converting enzyme inhibitors; ARB:Angiotensin II-receptor antagonist. 
10.1.1 Health related quality of life and depression/anxiety 
 
Figure 5. Results of the instrument KCCQ in study I, II measuring disease specific knowledge at baseline, three 
months and six months. Results from three months reprinted from Sc.Card.J with permission from Taylor & 
Francis. Results from six months are unpublished data. 
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The disease specific HRQoL measured by KCCQ improved with significantly higher score at 
three-month follow-up in study I (median IG 65.1 [IQR: 38.5, 83.3]) vs. CG (median 52.1 
[IQR:41.1, 64.1] p=0.05). Physical limitation improved (median IG (54.2 [IQR: 37.7, 83.3]) 
vs. CG (45.8 [IQR: 25.0, 54.2] p=0.05). After six months there was further improvement in 
disease specific HRQoL with median IG (72.7 [IQR: 50.8, 87.9]) vs. median CG (51.8 [IQR: 
40.9, 62.8] p=0,05) in study II (Figure 5). HRQoL measured by the generic instrument SF-36 
was not different between the two groups regarding mental or physical score at baseline three 
or six months follow-ups in study I and II. 
 
No significant differences were found between groups in patient-reported or clinical out-
comes at baseline in study IV. Yoga and hydrotherapy had equal impact between groups on 
disease-specific and generic HRQoL, anxiety and symptoms of depression after three months, 
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anxiety decreased (hydrotherapy P=0.03 and yoga P=0.01). Persons in the yoga group signifi-
cantly improved their generic HRQoL measured by EQ-VAS (P=0.004) and their disease-
specific HRQoL in the following domains of KCCQ; symptom frequency (P=0.03), self-effi-
cacy (P=0.01), clinical summary score as a combined measure of symptoms and social fac-
tors (P=0.05), and the total overall summary score for the whole instrument (P=0.04) and de-
creased their symptoms of depression according to PHQ-9 (P=0.005) (Table 6). 
10.1.2 Physical and clinical measurements  
In study IV no significant differences were found between the groups in any of the clinical or 
person-reported outcomes at baseline. Between groups there was no significant differences 
after three months Within group comparisons showed improved exercise capacity (hydrother-
apy p= 0.02 and yoga p=0.008) in both groups after three months. In study IV hydrotherapy 
training showed a significant improvement in lower limb muscle strength by STS test 
(p=0.01) (Table 7). 
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10.1.3 Self-care behavior and adherence 
The two groups IG and CG were balanced at randomization at baseline in both study I and II. 
Self-care behavior measured with EHFScB-9 after three months displayed an improvement in 
the IG median (17 [IQR: 13, 22]) in comparison with the CG median (21 [IQR: 17, 25]) 
(p<0.05) in study I. The same indication with lower results in EHFScB-9 indicating a better 
self-care behavior was also measured at the six months follow-up in study II median IG (16.5 
[IQR:12, 22]) vs. median CG (23.5 [IQR 18.8, 30,0] p=0,05) (Figure 6).  
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Figure 6. Results of the instrument EHFScB-9 measuring self-care behavior at baseline, three months and six 
months. Results from three months reprinted from Sc.Card.J with permission from Taylor & Francis. Results 
from six months are unpublished data. 
  
Figure 7. Adherence to the mHealth system during six months. Results from three months reprinted from 
Sc.Card.J with permission from Taylor & Francis. Results from six months are unpublished data. 
In study I II adherence to the mHealth system was high with a median of 85-88%. A post-hoc 
analysis was performed with a 60%-point adherence as cut off to test effects on cardiac hospi-
talization. For the subgroup of IG who displayed an adherence to the system > 60% there was 
a reduction of 5.6 hospital days per person. A statistical correlation was used for the fact that 
the group diminished further in size and the results were significant (p=0.05) (Figure 7). In 
study III adherence to mHealth was expressed as important and strengthened weighing per-
formance. 
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10.1.4 Disease specific knowledge 
There was no difference in disease specific knowledge measured with the instrument DHFKS 
at three months in study I which changed towards a significantly improved level of 
knowledge of HF at six months II (IG:12.8±1.7 vs. CG:12.1±1.9) with an 11% increase in IG 
and decrease by 1% in CG (p=0.05).  
10.1.5 Experiences and accessibility of mHealth 
In study II read information could be analyzed in the collected systems and demonstrated that 
persons who had used the mHealth system tended to actively choose to read topics that can be 
perceived as positive like “food and drink” whereas disease-oriented information were less 
likely to be studied. 
Study III resulted in an identification of eight sub-categories that emerged from the 310 num-
ber of meaning units and they could all be united within “the specific theory of heart failure 
self-care”. We named the subcategories as adherence, support, obstacle, physical features in-
dicating disease, psychological sensations, developing and using skills, independence and co-
operation. These subcategories could be detected within the three main predefined categories 
in the theory, self-care maintenance, symptom perception and self-care management and de-
veloped an understanding of acceptability, perceived usefulness and potential areas of sup-
port. 
10.1.6 Hospitalization 
Hospitalization was measured with HF related days in hospital and decreased after three 
months in study I with 1.3 hospital days/person in IG vs. 3.5 in CG (RR 0.38; 95% CI:0.31-
0.46; p=0.05). Follow-up with study II after six months demonstrated a significant reduction 
of HF related days in hospital by IG (RR:2.72, 95% CI:0.61-0.84, p=0,05) corresponding to a 
reduction of 2.7 days per patient over a six months period. In the IG there were 6.9 HF hospi-
tal days/ person vs. CG 9.6 HF hospital days/ person at six months (Figure 8). 
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Figure 8. Hospitalization days due to heart failure for all persons who entered the study I and II during six 
months. Results from three months reprinted from Sc.Card.J with permission from Taylor & Francis. Results 
from six months are unpublished data.  
 
Days 30 60 90 120 150 180
CG 0,7 2,48 4,53 6,71 8,38 9,63
IG 0,03 1,31 1,94 3,36 4,94 6,89
IG per-protocol 0,04 1,04 1,36 1,92 2,47 4,02
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11 DISCUSSION 
11.1.1 Principal observations 
The synthesis of this thesis showed that both the mHealth system and yoga enhanced and 
strengthened self-care and disease specific HRQoL. Persons with HF equipped with the 
mHealth system improved in self-care and experienced a better disease specific HRQoL to-
gether with a significant reduction of HF-related hospital days. These results sustained at six 
months follow-up together with an increase of disease specific knowledge. The adherence to 
the system was high. The invention mHealth system, was easy to use even for older persons 
with HF and improved self-care without increasing the burden on health care providers. The 
experiences of the mHealth system could be determined in relation to “the situation specific 
theory of heart failure self-care”. Technical adversities were considered an obstacle but not 
necessary a problem with a quick, easy technical support. Both yoga and hydrotherapy im-
proved in exercise capacity, HRQoL and decreased anxiety and depression. 
11.1.2 Comparison with previous studies 
11.1.2.1 Self-care by mHealth and yoga 
Self-care is needed in maintenance and management of a disease such as HF. Self-care is 
known both to have an automatic response to action due to values and motivation self-care 
has also the possibility to be a learned. Looking at self-care from that aspect it can be im-
proved by the increased use of mHealth but also through the effort of engaging in exercise 
like yoga and hydrotherapy. In the population of persons who have HF there are a lot of fac-
tors to consider when developing interventions to improve such an important process as self-
care. Experiences, skills, motivations, habits, cultural beliefs and values, functional and cog-
nitive abilities, confidence together with support and access to care, are all important and 
have their impact on self-care behavior (226). There are also other factors known to affect the 
interaction with self-care such as age, gender, depression, NYHA class, HRQoL, socioeco-
nomic factors as well as education (16, 48). In previous RCT studies examining persons with 
HF and their self-care behavior, significant improvements have been detected between IG us-
ing mHealth in comparison to CG (63, 84, 85, 91, 93, 227). In this thesis there were support 
of some of these findings. In study I and II the self-care behavior through using the mHealth 
system increased both after three and six months when we measured by EHFScB-9. 
Through a development of habits and knowledge connected to maintenance together with the 
assistance from the mHealth system about how and when to act within self-care management, 
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there was a feeling of self-confidence growing trough self-esteem expressed in study III. Fur-
ther, a motivation of weighing together with understanding its importance was created, devel-
oping a habit of adherence to self-care. Previous studies indicate that functional capacity and 
knowledge directly are associated with self-care management but also that health literacy and 
social support are directly related to self-care maintenance. Moreover, self-care confidence 
mediates the relationships between knowledge, health literacy, social support and self-care 
behavior within HF (61). As such it maybe the interaction of social support from relatives and 
partners that may have had an impact on the adherence to self-care maintenance in study I 
and II. Anyhow the increased self-care confidence understood by the experiences of the per-
sons used the mHealth could be a good foundation for both self-care maintenance and man-
agement. The impact seen by mHealth on self-care has also been reported in a recent review 
by Radhakrishnan with significant improvement in self-care behaviors such as daily weigh-
ing, medication management, exercise adherence, salt restriction and stress reduction. On the 
other hand five out of the 14 studies did not find any differences in self-care between IG and 
CG (228). 
All studies conducted in this thesis clearly supported the self-care process from various as-
pects, using different scientific methods, as quantitative RCT studies but also with a qualita-
tive approach with semi structured interviews. From a theoretical point of view the experi-
ences with the mHealth system in connection to self-care in study III could be interpreted in 
line with “the situation specific theory of heart failure self-care”(43). The mHealth used in 
earlier studies in the literature were developed with technical connections between the per-
sons home and the hospital. The mHealth system evaluated in this thesis seemed to offer 
something new in terms of accessibility together with the allocation of main responsibility for 
self-care to the person itself. The decision for actions was in the hand of the person or as a 
joint decision together with caregivers, when the mHealth system gave an indication to seek 
care. The system was designed in a way to make it easy to integrate in elderly persons daily 
lives and make them reflect over their condition with a direct response of suggested actions in 
case of deterioration. In study III experiences of performing something important true weigh-
ing was expressed. Their experiences of using the mHealth system with instructions on daily 
weight was vital and improvement in self-care management was developed possibly due to 
instant real-time instructions of how to manage a deterioration. 
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11.1.2.2 HRQoL, anxiety and depression 
The measurements of HRQoL are dividing evaluation through generic instruments and dis-
ease specific instrument. As the disease specific instruments are constructed to measure spe-
cifically HRQoL within the HF population, a use of only those instruments would perhaps 
have been more adequate to solely use in this thesis. On the other hand, there is an association 
between higher PA levels and a better generic HRQoL (EQ5D-VAS) which implies that ge-
neric HRQoL might be possible to improve by adopting a physical active life style as in study 
IV. In HF there are known factors that influences around 50% of poor HRQoL outcome, 
among those are psychological distress, poor health perception, higher NYHA grading and 
lower education level (30). The possibility to offer a wider variety of training options in-
cludes exercises at home like performance of yoga in attempt to improve HRQoL. In study 
IV with yoga, significant improvements were seen with results from within the yoga group 
from pre-posttests in HRQoL with EQ-VAS together with the domains of symptom fre-
quency, self-efficacy and both clinically and summary score of the disease specific question-
naire KCCQ. There was also significant improvement in depression within the yoga group in 
study IV which is known to be a significant predictor for outcomes in HF. Symptoms of de-
pression have a considerable overlap with other symptoms and are sometimes difficult to de-
tect. A recent meta-analysis observed the beneficial role of aerobic exercise training in per-
sons with HFrEF and relationship between depression and HF with respect to both epidemiol-
ogy and pathophysiological aspects (73). Psychological distress should be considered in fu-
ture efforts to address self-care and HRQOL in persons with HF (229). The results in study 
IV demonstrates significant differences from pre-to posttest in exercise capacity, depression, 
generic and disease specific HRQoL, reflecting a balance physically and mentally by yoga. 
Our findings are supported by a recent meta-analysis examining the effects of yoga compared 
to control with a positive impact of yoga on exercise capacity and HRQoL in persons with 
HF (188). Larger multicenter studies to generalize these results are needed to investigate what 
specific effects different parts of yoga are consisted. Although yoga shows benefit for persons 
with HF there is a lack of knowledge how yoga can support HRQoL in the best possible way. 
11.1.2.3 The mHealth system in aspect of adherence 
In this thesis the persons in study I and II had a high adherence of 85-88 % to the mHealth 
system. Measuring adherence can be considered from different aspects. Adherence to use a 
mHealth system is usually high around 70-90% (86, 87, 230). Depending on the type of 
mHealth system used and if the persons needs to rapport the self-care action e.g. weighing, 
medication intake etc. themselves through the system or if it is automatic, adherence can 
 58 
vary. On the other hand, the adherence to the self-care advices proposed within mHealth sys-
tems in general, shows various results of adherence within the same self-care advice. A novel 
study evaluated an online education and coaching program to promote self-care that was au-
tomatically tailored to the knowledge and behavior of the person with HF. Self-reported self-
care behavior in that study improved for daily weighing, low-salt diet and PA (231). There 
are other studies with short term adherence by three months with mHealth and weighing 
showing promising results (96, 145). Even though there are many barriers to optimal self-care 
it seems that adherence is usually high to self-care within mHealth.  
There are many difficulties initiating and maintaining exercise training in persons with HF. 
Even if the persons are well informed of the importance of exercise there are many barriers to 
get across to perform regular training. It can be physical symptoms and lack of energy and the 
adherence to exercise beyond six months is low (7, 139). In study IV the adherence to both 
yoga and hydrotherapy was high. Everybody included in the analysis in study IV performed 
at least 20 sessions supervised yoga or hydrotherapy during the three months of intervention. 
Longtime results are known to decrease in adherence concerning PA (100).  
Due to a higher shared HF knowledge and self-care adherence behaviors are more likely to be 
successful when persons with HF and their partners get information and support, the burden 
can be shared and the dyads can support each other (232, 233). This may also be a contrib-
uting factor to adherence to the mHealth system in our study, as 77% of the persons had a 
partner. In a review that examined 46 studies with both qualitative and quantitative design in-
vestigations with mHealth as part to support self-care. The use of mHealth could be identified 
as a solution for those living in rural areas and in remote places to provide access to special-
ized healthcare and self-care advices without frequent traveling. However, they demanded 
more comprehensive studies to strengthen education in self-care through technical support 
(234). 
11.1.2.4 Disease specific knowledge  
The instrument DHFKS measured knowledge in HF in general, symptom recognition and 
treatment. Ciere et al examined the effect of mHealth in a review consisting of 12 studies and 
found that increase in disease specific knowledge mediates improvement in HRQoL (98). To 
improve the development of knowledge to enhance self-care, detailed guidelines are now 
available (235). It is known that the perception of the complexity concerning the composition 
in the self-care process can differ. While the person with HF describes self-care regimen as 
hard work, the healthcare staff, may feel that the persons do not perform self-care even if the 
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instructions and actions are easy to perform. The persons with HF seem to need more 
knowledge with main emphasis on how self-care can be performed (236). Disease specific 
knowledge has been evaluated with the questionnaire DHFKS in concern to mHealth in a few 
RCT studies with an increase in level of knowledge in most of them (63, 90, 95, 96). On the 
other hand, not, everybody has found that knowledge increase using mHealth. Wakefield et al 
did not see any significant increase in level of knowledge (88). The disease specific 
knowledge in our studies I and II were also measured with the valid and reliably DHFKS in-
strument but nevertheless the disease specific knowledge measured high scores already at 
baseline and no significant differences after three months but a significant increase in 
knowledge at six months follow-up. 
11.1.2.5 Decrease in hospitalization with m-Health 
An important outcome in HF with mHealth is decrease of hospitalization and is highlighted in 
guidelines (4). To identify patterns of self-care behaviors in persons with HF and their associ-
ation with clinical events is of great value. A recent prospective cohort study identified three 
patterns of self-care behavior, poor symptom response, good symptom response, and mainte-
nance-focused behaviors. Patients with good symptom response behaviors had fewer clinical 
events compared with those who had poor symptom response behaviors. Persons with HF 
and poor symptom response behaviors had the most frequent clinical events (237). Therefore, 
it seems of highest importance that persons with HF learn how to manage their symptom de-
terioration. The result with decreased hospitalization in study I and II together with excellent 
adherence and positive experiences reported in study III with the mHealth system indicate a 
system with great potential for increased self-care. 
11.1.3 Strengths in this thesis  
In this thesis the greatest strength is the possibility to illuminate and explore the complicated 
self-care process and HRQoL from different aspects both with RCT studies I, II and IV to-
gether with experiences from interviews with persons who used the mHealth in study IV. The 
propositions made from Mays and Pope (238) was used to establish trustworthiness in the 
qualitative research in study III. To establish validity, reflexivity was described by personal 
characteristics like professional status of the interviewer. Negative cases with contradictory 
findings were highlighted. A clear exposition of the method of data collection and analysis 
was made, and interpretation was proffered adequately by support from the data. Sufficient 
data was collected from the persons interviewed to make saturation but also to make fair deal-
ing with incorporation of a wide range of perspectives. In study IV the persons were on opti-
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mal drug treatment and had been to an outpatient HF clinic with individually adjusted HF in-
formation when entering the study at baseline. Improvements in HRQoL and 6MWT on top 
of optimal treatment in both yoga and hydrotherapy strengthened the results. In study I and 
IV there was a random component in the sequence generation process such as sealed enve-
lopes prepared by a third person in advance. That person was not involved in the research 
process and shuffled envelopes as a safeguard at allocation. Concerning internal validity in 
study I, II and IV all the instruments used was tested for validity and reliability and used in 
HF population. As a strength a power analysis was performed in study I and II. To deal with 
the drop-out issues, external validity was considered acceptable as findings and conclusions 
in study I and II were made with sufficiently large samples.  
11.1.4 Limitations in this thesis 
The persons included in this thesis were in different stages in their HF condition. In study I 
40% of the study participants had de novo HF without proper levels of medication which 
could have had an impact on the improved results of the condition in HRQoL over time. In-
clusion criteria in study IV had an upper age limit of 80 years, although persons with HF are 
very often older than 80 years. There was a dissimilarity at baseline in study I and II regard-
ing atrial fibrillation which was more common in the CG and as atrial fibrillation is an im-
portant prognostic factor it could have affected the results. Hospitalization rate was not larger 
in the subgroup of atrial fibrillation and therefore it is unlikely that it had any impact on hos-
pitalization results. Concerning generalization, the study population were small in study I and 
II and study IV was a pilot study, so they should be considered as such, and the results cannot 
be generalized to the entire HF population. In study III all 32 persons who had tried the 
mHealth received an invitation letter offering to share their experiences in an interview, but 
reasons for not participating were not asked and 17 persons came to share their experiences in 
an interview, which may have led to a positive selection. All the persons showing up for in-
terviews had tried their best in being adherent to weighing. To optimize the reflexivity by 
avoiding influence of personal relation, a potential distance between person and interviewer 
was not considered. A triangulation in study III from the both the caregivers like partners and 
relatives but also the persons performing technical support of the mHealth system could have 
ensured comprehensiveness and encouraged a more reflective analysis of the data. The inter-
views were made after three months, thereafter the persons continued in the study for addi-
tional three months. This may of course have had an impact on evaluation of the six months 
result. More carefully gathering of background variables known as confounders concerning 
knowledge such as income and education levels could have gained a richer approach to some 
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of the questions raised in this thesis. The three months follow ups were made at the hospital 
in study (I, IV). At six months follow up in study II the questionnaires were sent home which 
may have affected the results. There was a lack of update of the mHealth system in study I 
and II both according to the change of guidelines that appeared during the study in fluid re-
striction and the dose of diuretics that was inscribed in the tablet only at the baseline. None of 
the studies were registered in any study base like for example “Clinical Trials.gov”. 
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12 CONCLUSIONS 
 The synthesis of this thesis showed that both the mHealth system and yoga 
enhached and streghtened self-care and disease specific HRQoL. 
 Persons with HF equipped with the mHealth system improved self-care and disease-
specific HRQoL after both three and six months without increasing the burden on 
health care providers. The adherence to use the mHealth system was high both at 
three and six months. 
 A significant reduction of HF-related hospital days was observed after both three 
and six months. 
 Increase in disease-specific knowledge expanded over time and gave a significant 
improvement after six months. 
 The experiences of the mHealth system revealed insight in the importance of 
adherence to the self-care process thought daily weighing. The importance was 
enhanced by the repeated reminder and instant feed-back from the mHealth-system 
and strengthened the feeling of safety and self-confidence together with a deeper 
understanding of cause and effect in self-care. The mHealth increased self-care 
maintenance and disease specific knowledge through understanding deteriorating 
symptoms and signs in connection to weight change with suggestions of self-care 
management. 
 Experiences of technical adversities were considered an obstacle with mHealth but 
not necessary a problem with quick and easy technical support. 
 The experiences of mHealth could be determined in relation to “the situation 
specific theory of heart failure self-care”. 
 Yoga and hydrotherapy had equal effect on HRQoL in persons with HF. Both yoga 
and hydrotherapy improved exercise capacity and decreased anxiety in persons with 
HF. Yoga was well tolerated and could be an alternative or complement to 
traditional forms of exercise training in HF. 
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13 FUTURE PERSPECTIVES 
This thesis has generated new questions and ideas for future research and inventions about 
self-care among persons with HF. All the studies performed in this thesis was relevant in add-
ing new knowledge in the area.  
 Develop mHealth and test interventions together with yoga. 
 Develop and test a yoga model or theory for persons with HF.  
 Further explore how to support partners in the area of mHealth. 
 Further explore the cognitive effects but also depression and anxiety within yoga. 
 Develop new instrument for measurement of yoga in HF. 
 Gender perspective concerning HF and yoga to enhace self-confidence. 
 Evaluation of hospitalization in larger multicentered trials are needed with yoga in HF 
population. 
 Health-economic evaluation of cost-effectiveness is needed in larger populations with 
mHealth. 
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14 SAMMANFATTNING (SUMMARY IN SWEDISH) 
Hjärtsvikt påverkar mer än 38 miljoner människor världen över idag och det är extremt vik-
tigt att stärka deras egenvård. I Sverige är den totala förekomsten av hjärtsvikt ca 2–3%. 
Hjärtsvikt drabbar främst äldre och medelåldern är 75 år och över 80 års ålder kan ca 10–20% 
av befolkningen ha utvecklat hjärtsvikt. Två procent av Sveriges totala sjukvårdskostnader är 
relaterade till hjärtsvikt och 75 % av kostnaderna orsakas av sjukhusvistelse. Egenvård inne-
fattar en beslutsprocess som både är förebyggande för hälsan och hanterande av kronisk sjuk-
dom, med kärnelement som egenvårds-beslut, egenvårds-övervakning, och egenvård-hante-
ring. Det anses vara av yttersta vikt vid kronisk sjukdom och både nationella och internation-
ella riktlinjer ger tydliga rekommendationer för egenvård vid hjärtsvikt. Idag i samhället finns 
en trend mot ökad användning av teknik i olika former som exempelvis mHealth för att stärka 
egenvården. Inom mHealth-konceptet är telemonitorering en del som övervakar försämring 
av sjukdomstillstånd med eller utan överföring av fysiologiska data. Mycket talar för att 
mHealth påverkar sjuklighet och dödlighet, men också förbättrar egenvård och livskvalitet. 
Det gäller även egenvård med fysisk aktivitet och träning där fördelarna är väl dokumente-
rade. Fysisk träning vid hjärtsvikt är inte bara säker utan också associerad till minskad risk för 
sjukhusvistelse, minskad dödlighet samt ökad livskvalitet. Det finns stort intresse och stor 
potential att förbättra och intensifiera egenvårdsprocessen hos personer med hjärtsvikt, tex 
nya fysiska träningsmetoder som är individualiserade och baserade på personliga preferenser. 
Syftet med denna avhandling var att beskriva erfarenheter och utvärdera effekterna av nya 
metoder för att stödja egenvården genom ett mHealth system och yoga hos personer med 
hjärtsvikt.  
I studie I utvärderade vi ett nytt mHealth system bestående av en specialiserad programvara i 
en pekplatta som var trådlöst ansluten till en våg. Pekplattan innehöll förutom livsstilsråd för 
personer med hjärtsvikt enligt gällande riktlinjer också aktuell föreslagen dos av diuretika 
samt förändringar i vikt och livskvalitet över tid. Personer med hjärtsvikt (n=82) randomise-
rades från tre sjukhus till kontrollgrupp eller att använda mHealth systemet i tre månader. 
Studien visade en signifikant ökad egenvård, hälsorelaterad livskvalité samt minskade sjuk-
husdagar pga. hjärtsvikt för de som använde mHealth systemet.  
I studie II utvärderades mHealth systemet i samma population efter sex månader. Syftet var 
att utvärdera långtidseffekter och det visade fortsatt signifikant förbättrad egenvård, hälsore-
laterad livskvalitet och minskade sjukhusdagar. Långtidsuppföljningen visade även ökad kun-
skap om hjärtsvikt. 
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I studie III utforskades erfarenheterna hos 17 personer med hjärtsvikt som hade använt mHe-
alth systemet i tre månader. En kvalitativ studiedesign med halvstrukturerade intervjuer ana-
lyserades deduktivt med en teoretisk grund från "the situation specific theory of heart failure 
self-care". Intervjuerna speglade erfarenheterna av vägning, intag av diuretika med och ge-
nom påminnelser i mHealth systemet och på så sätt stärktes egenvården hos personer med 
hjärtsvikt. Erfarenheterna av mHealth systemet kunde sammankopplas med den teoretiska ba-
sen i "the situation specific theory of heart failure self-care". Tekniska motgångar i vågen och 
pekplattan ansågs vara ett hinder med inte ett problem eftersom det fanns snabb teknisk sup-
port.  
I studie IV undersökte vi om yoga och hydroterapi hade samma effekt på hälsorelaterad livs-
kvalitet hos personer med hjärtsvikt. Vi jämförde också effekter på träningskapacitet, kliniska 
resultat, ångest och depression. Totalt 40 personer randomiserade till tre månader med träning 
av yoga eller med hydroterapi två gånger i veckan. Yoga och hydroterapi hade lika stor inver-
kan på livskvalitet, träningskapacitet, kliniska utfall, ångest och depression med förbättring i 
bägge grupperna. Inom yogagruppen sågs signifikanta förbättringar gällande hälsorelaterad 
livskvalitet samt att depression minskade. Inom hydroterapigruppen förbättrades muskelstyr-
kan i de nedre kroppsdelarna signifikant. 
Sammanfattning 
Personer med hjärtsvikt som fick stöd i egenvård genom mHealth systemet visade ökad egen-
vård, hälsorelaterad livskvalitet samt minskat antal sjukhusdagar efter tre och sex månader. 
Efter sex månader hade också sjukdomsspecifik kunskap förbättrats. Följsamheten till väg-
ning och justerat intag av diuretika var genomgående bra med m-Health systemet och erfa-
renheterna kunde kopplade till teorin "the situation specific theory of heart failure self-care". 
För att öka hälsorelaterad livskvalitet och minska depressiva symtom hos personer med hjärt-
svikt kan yoga vara ett alternativ eller komplement till etablerade former av fysisk träning. 
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16 APPENDIX 1 
 
 
 
 
Program 1 
 
Keep your eyes closed all through the set and focus on a point between the eye brows (3.rd eye). Use a 
mental mantra: SAT NAM, Sat on the inhale and Nam on the exhale. Tune in before the set and tune 
our after the set. 
 
 
1. Corps Pose – Long deep breathing 
Lie flat on your back, Relax and do long deep 
breathing through your nose. 5-11 minutes. 
 
 
2. Spine Flexing 
Sit with your legs crossed and a straight spine, 
hold on to your ankles. Start flexing the spine 
back and forth, slowly, inhaling going forward, 
exhaling going backwards. 3-5 minutes. End 
with contraction of the muscles around the 
anus, urinary tract and navel-(Rootlock). 
Relax. 
 
 
 
3. Sat Kriya 
Sit on your heels, spine straight, interlace your 
fingers, extend your index fingers pointing 
upwards. Stretch your arms above your head 
no bend in the elbows, upper arms hugging 
your ears. Say out loud the mantra Sat 
squeezing the navel and a full Rootlock. Say 
Nam as you relax and release the belly, let the 
breath come naturally. 3 minutes. Relax. 
 
 
 
Meditation - Guru Ram Das  
 
 
 
 
 
 
 
 
Sit cross legged, the palms of your hand against the heart, the left hand 
inside the right. Focus on your heart and repeat the mantra: 
Guru Guru Wahe Guru, Guru Ram Das Guru.  
(the wisdom that comes as a servant of the Infinite), 7-11 minutes. End 
the set. 
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Program 3 
 
 
Performe the exercises slowly and gently. The practicing should never cause pain. Inhale through the 
nose, mentally vibrate the mantra SAT, Exhale through the nose, vibrate NAM. Long slow breathing. 
Keep your eyes closed through the set.  
 
 
1. Breath of Fire. Spine straight. Arms up 60 
degrees. Inhale and exhale with short rapid 
movements in the stomach. 1 minute. Rootlock. 
Take your arms down. Relax. 
 
 
2. Spine Flex Spine straight. Move it forward 
with hands on your knees, inhale, Exhale when 
you flex backwards. 1-3 minutes. End with 
Rootlock. Relax.  
 
 
3. Spine Twist. Hands on your shoulders. 
Fingers forward and thumbs down the back. 
Elbows out to the sides. Inhale, twist to the left. 
Exhale, twist to the right 1-3 minutes. Relax. 
 
 
4. Side Bending. Hand in the same way as in 
exercise nr 3. Inhale and bend sideways down 
to the left, exhale over down to the right. 1-3 
minutes. Relax. 
 
 
5. Neck Roll. Spine straight, start rolling the 
neck, slowly, clockwise. Ten laps. Reverse and 
roll it counter clockwise another ten laps Make 
sure there is no pain in the neck during the 
exercise. Then, sit straight up and relax 3-5 
minutes with your eyes closed  
 
Meditation 
 
Sit in a comfortable position, spine straight, 
eyes closed, focus in your 3rd eye point between your eye brows. Left 
hand in your lap, there press thumb against forefinger. Lift your right hand 
to your face. Press your right thumb against your right nostril, inhale 
through your left nostri l. Hold. Now move the forefinger on your right 
hand and press it against your left nostril, at the same time release the 
thumb. Exhale through your right nostril. Switch back again so that you 
inhale through your left nostril and exhale through your right nostril. Keep 
this up for 11 minutes, then rest. 
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